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This dissertation presents three new mouse models that help to study the functions of Enpp1, 
Atp6v1b1, and Tbx1 for ear development and function. asj (aging with stiffened joints) carries a 
missense mutation in the mouse Enpp1 gene. Enpp1 encodes the enzyme ENPP1 that regulate soft-
tissue calcification and bone mineralization, and is associated with generalized arterial calcification of 
infancy and hypophosphatemic rickets in human patients. asj mutant mice show severe middle ear 
infection and tissue calcification, which provide a new mouse model to study otitis media and 
tympanoscleorosis.  Atp6v1b1 encode a protein that is a subunit of the V-ATPase pump, which is the key 
regulator of pH homeostasis. Atp6v1b1 mutation is associated with human distal renal tubular acidosis 
(dRTA) with hearing loss; however, Atp6v1b1 knockout mice have mild kidney phenotype and normal 
hearing. vtx (vortex) mice carry a missense mutation in the mouse Atp6v1b1 gene on a MRL.Mpj 
background, that shows severe hearing loss and vestibular dysfunction. Transfer the vtx mutation to a 
B6 background did not cause hearing loss, indicating genetic background effects underlie this variation. 
We performed linkage backcross to map the genetic loci that modify the degree of hearing loss on the 
two different background strains and found statistically significant linkage with a region on Chr13. 
Because MRL-vtx mice exhibit enlargements of the endolymphatic sac and duct in the inner ear but do 
not exhibit the overt metabolic acidosis characteristic of dRTA, they provide a new genetic model for 
 
 
nonsyndromic deafness with enlarged vestibular aqueducts. TBX1 haploinsufficieny is associated with 
human DiGeorge syndrome. Tbx1 knockout mice are embryonic lethal and ear morphogenesis stops 
around E10 in the mutant mice. Study showed expression of TBX1 in the stria vascularis and vestibular 
dark cells, but because Tbx1 KO mice don’t have fully developed inner ear, new model is required to 
study Tbx1 function at later development stage. Tbx1wdml (windmill) mice carry a missense mutation in 
the mouse Tbx1 gene and have fully developed inner ear. Hearing loss and vestibular dysfunction 
correlate well with TBX1 expression in the stria vascularis and dark cells. This new Tbx1 mouse model 
provides a valuable tool to study Tbx1 function in the development of stria vascularis and semicircular 
canal. 
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CHAPTER 1 ECTOPIC MINERALIZATION AND CONDUCTIVE HEARING LOSS IN ENPP1ASJ MUTANT MICE, 
A NEW MODEL FOR OTITIS MEDIA AND TYMPANOSCLEROSIS 
1.1 Introduction 
 While many genes have been discovered that underlie Mendelian forms of sensorineural 
hearing loss (http://hereditaryhearingloss.org/), most cases of conductive hearing loss, often caused by 
otitis media and tympanosclerosis, have complex and poorly understood etiologies. Otitis media is an 
inflammation of the middle ear and is among the most common childhood illnesses. Heritability studies 
have shown that genetic factors can play an important role in otitis media susceptibility, but few 
contributing genes have been identified in human populations [1]. In contrast to human studies, a 
growing number of mouse mutations have been identified that manifest a high incidence of otitis media, 
including Eya4, Tlr4, p73, MyD88, Fas, E2f4, Plg, Fbxo11, Evi1[1, 2], Sh3pxd2b[3], Rpl38[4], Isl1[5], 
Chd7[6], Lmna1[7], Phex[8], Oxgr1[9], Tgif1[10], and Mcph1[11]. The wide diversity of these genes and 
their mutant pathologies, including craniofacial abnormalities with Eustachian tube malformations and 
innate immune response defects, underscores the complex nature of otitis media.  
 Here we report on the conductive hearing loss associated with a recessive ENU-induced 
missense mutation of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene (Enpp1) that was 
discovered at The Jackson Laboratory and named "ages with stiffened joints" (asj) because of the 
progressive ankylosis and osteoarthritis exhibited by mutant mice [12]. The Enpp1 gene encodes an 
enzyme (ENPP1) that regulates soft-tissue calcification and bone mineralization by producing inorganic 
pyrophosphate, a major inhibitor of calcification. A previous analysis of asj mutant mice found that 
enzymatic activity of ENPP1 in the liver and inorganic pyrophosphate (PPi) levels in plasma were 
markedly reduced[13]. Other mouse mutations of Enpp1 have been reported, including the naturally 
occurring "tiptoe walking" (ttw) nonsense mutation[14], an ENU-induced C397S missense mutation[15], 
and a genetically engineered knockout mutation[16].  The Enpp1 mutant mice in these studies exhibited 
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extensive mineralization defects in a number of tissues, including spinal ligaments, long bones, articular 
cartilage, heart, aorta, arterial blood vessels, vibrissae, liver, kidneys, and retina. The effects of the 
Enpp1 mutations on auditory function and middle and inner ear histology of mice, however, were not 
examined.  
 We show here that Enpp1asj mutant mice exhibit a conductive hearing loss that is associated 
with middle and inner ear mineralization abnormalities. These mice provide a new animal model for 
studies of otitis media and tympanosclerosis and for the hearing loss recently shown to be associated 
with human ENPP1 mutations causing generalized arterial calcification of infancy and 
hypophosphatemic rickets[17, 18]. 
1.2 Materials and Methods 
1.2.1 Mice  
 The recessive asj mutation was discovered at The Jackson Laboratory in 2004 in the C57BL/6J 
progeny of an ENU treated C57BL/6J male. The mutant strain name is C57BL/6J-Enpp1asj/GrsrJ and is 
available from The Jackson Laboratory (Stock #012810). Experimental mice were housed in the Research 
Animal Facility of The Jackson Laboratory, and all procedures involving their use were approved by the 
Institutional Animal Care and Use Committee. The Jackson Laboratory is accredited by the American 
Association for the Accreditation of Laboratory Animal Care. 
1.2.2 Genotyping the Enpp1asj mutation 
 The asj mutation is a single nucleotide substitution of T to A in exon 7 of the Enpp1 gene 
resulting in an amino acid substitution from valine to aspartic acid at residue 246 (p.V246D) of protein 
Reference Sequence NP_032839 . The T to A point mutation (nt 848 of mRNA Reference Sequence 
NM_008813) creates a new TaqI restriction site (TCGA), which is the basis of the genotyping method 
described by Harris and colleagues[12] and that was used in this study to distinguish wild-type from 
mutant alleles. 
 
 
3 
1.2.3 Assessment of hearing by ABR  
 Hearing was evaluated in anesthetized (Avertin, 0.4 mg/g mouse mass) wild-type, Enpp1asj/+, and 
Enpp1asj/asj mice by measuring auditory brainstem response (ABR). A computer-aided evoked potential 
system (Intelligent Hearing Systems) was used to measure mouse ABR thresholds as previously 
described [19]. 
1.2.4 Histological analyses of middle and inner ears 
 Histological analyses of the middle and inner ears were performed following the methods 
described previously[20]. Briefly, middle and inner ears from Enpp1asj/asj mice and wild-type mice were 
dissected after transcardial perfusion with Bouin’s fixative. Ear samples were immersed in Bouin’s 
fixative (7 days for one-month-old mice and 30 days for mice older than 6 months) and embedded in 
paraffin. Sections (7 mm) were cut and mounted onto Fisher Superfrost Plus slides (Fisher Scientific, 
Pittsburgh, PA) and counterstained in hematoxylin/eosin (H&E). Goblet cells, whose sole function is to 
secrete mucus, were identified by Mayer’s Mucicarmine staining method following the protocol 
provided by Electron Microscopy Sciences (Catalog #26320). The stepedial artery was dissected from 6-
month-old control and mutant mice, sectioned without decalcification, and stained with Alizarin red 
following standard procedures[21]. 
1.2.5 Evaluation of pathology of middle ears 
 A scoring system of -/+/++/+++ was used to assess the severity of pathology in the middle ears 
following a previously described method with modifications[22]. Histological analysis of the middle ears 
of control and mutant mice was performed using an Olympus BX51 microscope. A ‘-’ symbol was 
assigned when the pathology is absent in the middle ear. A ‘+’ symbol was assigned when pathology was 
very scarce in the middle ear. A ‘++’ symbol was assigned when pathology was more prevalent, but not 
to the point of spanning the entire middle ear. A ‘+++’ symbol was assigned when pathology spanned 
the entire middle ear. The following pathologies were evaluated by this scoring system: middle ear 
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effusion, inflammatory cell infiltration, tissue proliferation (epithelial hyperplasia), abnormal tissue at 
the Eustachian tube opening in the middle ear cavity, ectopic mineralization, and clusters of goblet cells. 
1.2.6 Scanning electron microscopy (SEM) 
 Middle ears from Enpp1asj/asj and wild-type mice were dissected after transcardial perfusion with 
4% paraformaldehyde (PFA) and then immersed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH= 
7.2) at 4°C overnight. Dissection was performed to expose the middle ear cavities. After three 15-minute 
washes with cacodylate buffer (pH= 7.2) at room temperature, samples were post-fixed with the 
osmium-thiocarbohydrazide-osmium-thiocarbohydrazide-osmium (OTOTO) method[23], and 
dehydrated in increasing concentrations of ethanol at 4°C. Samples were critical point dried with 
Hexamethyldisilazane (HMDS) and then air dried in fume hood. Samples were then coated with 15nm 
gold and analyzed in a Hitachi S-3000 scanning electron microscope (Hitachi, Tokyo, Japan) at 20 kV. 
1.3 Results 
1.3.1 Hearing impairment in Enpp1asj mutant mice 
 Hearing in the Enpp1 mutant mice and age-matched controls was evaluated by ABR threshold 
analysis. Initial ABR measurements of three-month-old mutant mice revealed a moderate to severe 
hearing loss with threshold increases of 25-35 decibels (dB) compared to the normal thresholds in the 
control mice for both click and all pure tone stimuli (8 kHz, 16 kHz, 32 kHz). To further characterize the 
hearing ability of Enpp1asj/asj mice and to determine whether the hearing impairment is progressive with 
age, recurrent ABR measurements were performed in Enpp1asj/asj, Enpp1asj/+, and Enpp1+/+ littermates 
from 3 weeks to 30 weeks of age (Figure 1.1, Table 1.1, Table 1.2). Enpp1asj/+ and Enpp1+/+ mice (grouped 
as controls) showed normal ABR thresholds even at 30 weeks of age, whereas Enpp1asj/asj mice exhibited 
elevated thresholds by 6 weeks of age. Hearing impairment is not congenital as mutant mice had normal 
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ABR thresholds at weaning age (3 weeks). Hearing loss in mutant mice progressed in two stages: average 
ABR thresholds increased by about 30-35 dB between 3 and 6 weeks of age, were relatively stable 
between 6 and 12 weeks, increased another 20-25 db between 12 and 18 weeks, and remained stable 
between 18 and 30 weeks. At 12 weeks of age, only one out of 11 Enpp1asj/asj mice tested showed 
normal thresholds in both ears (Table 1.1), giving a rough estimate of hearing loss penetrance of about 
90%. No head bobbing or circling behaviors were observed in the mutant mice at all ages, indicating 
normal vestibular function.  
 
Figure 1.1 Progressive hearing loss in Enpp1asj/asj mice 
ABR threshold means are shown for Enpp1asj/asj mice and littermate control mice, tested at the ages of 3 (n=6 
mutant ears/8 control ears), 6 (n=10/10), 8 (n=6/6), 12 (n=22/16), 18 (n=8/6), 26 (n=10/8), and 30 (n=12/14) 
weeks. Starting from 6 weeks of age, the mutant mice exhibit significantly higher mean ABR threshold values at 
all the stimulus frequencies tested (click, 8 kHz, 16 kHz, 32 kHz) compared to those of the littermate controls. 
Thresholds of mutant mice continue to increase with age and by 18 weeks most of the Enpp1asj/asj mice are 
profoundly hearing impaired. The increase in 32 kHz ABR thresholds of the control mice is due to the B6 
background, a strain known to exhibit age-related hearing loss starting at high frequencies. Error bars indicate 
standard errors of the mean.   
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Table 1.1 ABR thresholds of asj/asj mutant mice (* Highlighted ID numbers indicate ears were 
examined for pathology)  
Mouse Age Test 
 
 Right Ear thresholds (db SPL) Left Ear thresholds (dB SPL) 
 ID  *  
 
Days Sex Click 8 
 
16 
 
32 
 
Click 8 
 
16 
 
32 
 5729 3 wk 23 F 30 30 10 35 40 45 15 35 
5055 * 3 wk 22 M 30 40 10 40 35 40 15 40 
5738 3 wk 25 M 30 20 10 40 30 30 10 35 
4195 * 6 wk 38 M 35 70 50 80 75 80 60 70 
5001 6 wk 39 F 70 80 40 70 45 50 30 60 
5003 6 wk 39 M 60 80 40 80 60 90 50 70 
4094 * 6 wk 41 F 70 80 70 70 75 80 55 70 
4098 6 wk 41 M 35 70 50 60 70 80 60 70 
3915 8 wk 50 F 75 80 50 85 70 75 40 80 
3891 * 8 wk 55 F 35 60 35 45 75 75 55 75 
3893 * 8 wk 55 M 75 85 75 70 75 85 70 75 
3902 12 wk 75 F 45 50 30 40 40 50 30 40 
3904 12 wk 75 M 65 75 40 70 40 40 40 50 
3905 * 12 wk 75 M 30 50 20 40 80 85 60 90 
3899 * 12 wk 75 F 60 65 50 70 70 85 50 65 
4038 12 wk 89 F 100 90 60 90 80 80 50 70 
4039 12 wk 89 F 65 80 40 70 80 80 50 80 
4040 12 wk 89 M 70 80 60 90 70 85 50 90 
4030 12 wk 101 F 90 90 80 90 90 90 80 90 
4033 12 wk 101 M 60 80 70 70 40 60 60 70 
4034 12 wk 101 M 40 70 50 70 70 80 50 80 
4035 12 wk 101 M 70 80 50 70 40 50 50 60 
5005 18 wk 123 F 95 100 95 100 100 100 95 100 
5007 18 wk 125 F 90 100 70 90 60 90 50 90 
5010 18 wk 136 F 90 100 70 85 80 90 80 75 
5008 18 wk 144 F 80 90 70 90 90 90 80 90 
3884 * 26 wk 172 M 100 100 90 90 75 100 60 100 
3885 * 26 wk 172 F 90 100 70 80 100 100 100 100 
3886 26 wk 172 M 100 100 90 90 70 85 70 60 
3906 26 wk 188 F 100 100 80 100 95 90 70 100 
3913 26 wk 188 M 60 70 40 90 60 60 30 70 
3106 30 wk 202 F 100 100 100 100 90 90 70 100 
3107 30 wk 202 F 100 100 90 100 100 100 90 100 
3283 30 wk 204 F 100 100 90 100 100 100 90 100 
3098 30 wk 206 F 80 90 80 90 50 80 40 70 
3102 30 wk 206 M 70 80 70 90 90 90 60 90 
3286 30 wk 223 M 80 90 50 100 50 80 50 100 
3290 30 wk 223 M 100 100 90 100 80 80 65 90  
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Table 1.2 ABR thresholds of +/+ or +/asj control mice (* Highlighted ID numbers indicate ears were 
examined for pathology  
Mouse Age Test 
 
 Right Ear thresholds (db SPL) Left Ear thresholds (dB SPL) 
 ID *  
 
Days Sex Click 8 
 
16 
 
32 
 
Click 8 
 
16 
 
32 
 5044 3 wk 21 F 35 30 20 40 40 40 20 40 
5045 3 wk 21 M 35 30 20 35 30 30 20 30 
5054 3 wk 22 F 35 40 10 30 30 30 10 30 
5056 3 wk 22 M 33 30 10 30 40 40 20 30 
4193 * 6 wk 38 M 30 30 10 40 35 30 20 40 
5002 6 wk 39 F 20 20 10 30 40 30 15 40 
5004 6 wk 39 M 30 40 10 40 30 40 10 40 
4095 * 6 wk 41 F 30 40 20 50 35 40 20 50 
4097 6 wk 41 M 30 30 10 40 40 30 15 30 
3914 8 wk 50 F 30 40 25 50 35 40 30 50 
3888 8 wk 55 F 25 30 20 40 35 40 20 40 
3892 * 8 wk 55 M 40 50 25 50 40 40 10 30 
3900 * 12 wk 75 F 30 35 10 40 30 35 20 40 
3901 12 wk 75 F 30 40 25 50 60 60 35 60 
3903 12 wk 75 F 25 30 20 40 35 30 20 40 
4036 12 wk 89 F 35 30 10 30 50 35 15 40 
4037 12 wk 89 F 50 55 35 70 35 40 20 40 
4032 12 wk 101 M 25 30 10 40 35 30 10 40 
4029 12 wk 101 F 35 40 10 40 40 40 10 40 
4031 12 wk 101 M 30 40 10 40 35 50 10 40 
5006 18 wk 123 F 35 30 10 30 35 40 20 40 
5011 18 wk 136 F 30 50 10 60 35 50 20 40 
5009 18 wk 144 F 35 30 30 60 45 30 20 80 
3883 * 26 wk 172 F 40 40 20 80 40 50 20 60 
3887 * 26 wk 172 M 40 60 30 70 40 60 40 50 
3910 26 wk 188 M 35 30 10 70 40 40 10 80 
3911 26 wk 188 F 30 40 20 50 40 40 20 70 
3110 30 wk 202 F 30 40 20 40 30 40 20 40 
3112 30 wk 202 M 30 40 20 50 30 40 20 50 
3286 30 wk 204 M 30 30 20 45 40 40 20 50 
3101 30 wk 206 M 35 40 20 40 45 40 30 40 
3104 30 wk 206 M 30 30 10 40 40 40 20 45 
5014 30 wk 231 F 40 50 30 80 50 40 30 90 
5012 30 wk 234 F 40 50 40 85 50 50 40 90 
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1.3.2 Otitis media with effusion in Enpp1asj/asj mice 
 To assess the causes of hearing impairment in the Enpp1asj/asj mice, anatomical analysis of the 
middle and inner ears was performed after the completion of ABR measurements. We processed the 
whole bullae for histological studies, which allowed us to observe both middle and inner ear 
morphology. We did not observe any obvious inner ear defects in the asj mutant mice, such as hair cell 
and spiral ganglion cell loss, or stria vascularis degeneration (Figure 1.3H). However, we observed major 
histopathology in the middle and outer ear, with details described below.  
1.3.2.1 Middle ear effusion and epithelial proliferation in Enpp1 mutant mice.  
 All ears from Enpp1asj/asj mice that had elevated ABR thresholds (n= 11) exhibited defects in the 
middle ear including retracted tympanic membranes and middle ear cavities filled with effusion (Figures 
2, 3, Table 1.3) and a thickened epithelium with fibrous polyps (Figures 1.2B, 1.2D, 1.3C, Table 1.3). In 
addition, older Enpp1asj/asj mice exhibited excessive accumulation of discharge in the external ear canal 
(Figure 2H). All the ears from the control Enpp1+/asj and Enpp1+/+ mice examined (n =12) showed a 
transparent tympanic membrane, a clear middle ear cavity lined with a thin epithelium. 
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Figure 1.2 Otitis media in Enpp1asj/asj mice 
A, B: Representative images of pathological changes in the middle ears of Enpp1asj mutant mice (B) compared 
with controls (A) at the age of 5 months. The middle ear cavity (MEC) of Enpp1asj mutant mice is filled with 
effusions (black asterisk), fibroblastic and amorphous tissue masses (long arrows), and inflammatory cells 
(arrow head). Ectopic mineralization of the otic capsule is also evident in mutant mice (open arrow in B). 
Control mice show a clear middle ear cavity without fibroblastic proliferation (A). C, D: The thickness of the 
middle ear epithelium (double headed arrows) is greater in Enpp1asj mutant mice (D) than controls (C).  E, F: 
The stapedial artery wall (arrows) is thicker in Enpp1asj mutant mice (F) than controls (E). G, H: Representative 
images of discharge in mutant mice (H) and littermate controls (G) at the age of 5 months. The external ear 
cavity of the mutant mice is filled with discharge (red asterisk), while control mice have a clear external ear 
canal and easily observable tympanic membrane (black asterisk). Scale bars: A, B = 200μm, C, D = 50μm, E, F = 
80 μm.  
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Figure 1.3 Development of otitis media in Enpp1asj/asj mice.  
A-D: 6-12 week time course of middle ear pathology of Enpp1asj mutant mice (B, C, D) compared with a 12-
week-old control (A). At 6 weeks of age (B), an aqueous effusion (black asterisk) and a slightly thickened 
epithelium (arrow) are observed in the middle ear cavity of the Enpp1asj mutant mice. At 8 weeks (C), the 
middle ear cavity of the Enpp1asj mutant mouse is filled with an aqueous effusion (black asterisk) and contains 
amorphous tissue masses (green asterisk). The middle ear epithelium is much thickened (arrow), and the otic 
capsule exhibits regions of ectopic mineralization (arrowhead) with adjacent fibroblastic proliferation. At 12 
weeks (D), the middle ear cavity of mutant mice is filled with pus-like secretions (black asterisk), a thickened 
epithelium (arrows), and an amorphous tissue mass (green asterisk). E, F: Eustachian tube morphology of 
mutant (F) and control (E) mice at 12 weeks of age. In mutant mice, an amorphous tissue mass (green asterisk) 
is present near the orifice of the Eustachian tube (empty arrow), which may impede Eustachian tube function 
and lead to an accumulation of effusion in the middle ear cavity. G, H: Cochlear morphology and round window 
membranes of mutant (H) and control (G) mice. Cochlear morphology is grossly normal in Enpp1asj mutant mice 
compared with controls; however, the round window membrane (black arrow) of mutant mice is thicker. MEC: 
middle ear cavity. Scale bars: A, B, C, D, E, F = 200μm, G, H = 100μm. 
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Table 1.3 Histological assessment of the middle ears of the Enpp1 mutant and control mice  
Mouse ID Age Genotype MEE EH IC ETO EM CGC 
4012L 1wk Control - + - N/A - - 
4017 1wk Control - - - N/A - - 
4015L 1wk Control - - - N/A - - 
4016L 1wk Mutant - - - N/A - - 
4016R 1wk Mutant - - - N/A - - 
4018L 1wk Mutant - + - N/A - + 
4022L 2wk Control - - - N/A - - 
4022R 2wk Control - - - N/A - - 
4019R 2wk Control - - - N/A - - 
4023L 2wk Mutant - + - N/A - - 
4023R 2wk Mutant - + - N/A - - 
4020L 2wk Mutant - ++ + N/A - - 
4008L 2wk Mutant - + - N/A - - 
4008R 2wk Mutant - + - N/A - - 
4007L 2wk Mutant - + - N/A - + 
4007R 2wk Mutant - + - N/A - + 
4002L 3wk Control - - - N/A - - 
4002R 3wk Control - - - N/A - - 
4001L 3wk Control - - - N/A - + 
4001R 3wk Control - - - N/A - + 
4004L 3wk Mutant - - - N/A - - 
4004R 3wk Mutant - - - N/A - - 
4000L 3wk Mutant - - - N/A - - 
4000R 3wk Mutant - - - N/A - - 
5055R* 3wk Mutant - + - N/A - - 
5055L* 3wk Mutant - + - N/A - - 
4193R* 6wk Control - + - N/A - + 
4195R* 6wk Mutant + - - N/A + + 
4094R* 6wk Mutant +++ +++ + N/A + +++ 
3892L* 8wk Control - - - - -  
3893R* 8wk Mutant +++ +++ + +++ + ++ 
3891R* 8wk Mutant + + - N/A + - 
3900R* 12wk Control - - - N/A + - 
3905L* 12wk Mutant +++ +++ ++ N/A + +++ 
3905R* 12wk Mutant + + + + + - 
3899L* 12wk Mutant + +++ ++ +++ + +++ 
3899R* 12wk Mutant ++ +++ ++ N/A + ++ 
3883L* 26wk Control - - - N/A - - 
3883R* 26wk Control - - - - - - 
3887L* 26wk Control - - - N/A - + 
3887R* 26wk Control - - - - - - 
3884L* 26wk Mutant +++ ++ ++ ++ - +++ 
3884R* 26wk Mutant + ++ + ++ + + 
3885L* 26wk Mutant - - + - - + 
3885R* 26wk Mutant ++ ++ +++ ++ - ++ 
2094R 30wk Mutant ++ ++ ++ + + ++ 
2096R 30wk Mutant +++ +++ +++ ++ + ++ 
2098R 30wk Mutant +++ +++ ++ +++ + ++ 
 
MEE: Middle Ear Effusion; EH: Epithelial Hyperplasia; IC: Inflammatory Cells; ETO: Eustahian Tube Opening; EM: 
Ectopic Mineralization; CGC: Cluster of Goblet Cells.* Indicate ears with ABR data.  
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1.3.2.2 Increased goblet cell density and mucin secretion in Enpp1asj/asj mice.  
 In the epithelium lining the middle ear cavity and the Eustachian tube, mucins secreted by 
goblet cells build the first line of defense in protecting the host from invading pathogens; movements of 
the cilia then help to get rid of the pathogens, with mucins serving as a lubricant [24]. However, when 
chronic inflammation is present, some of the epithelial cells transdifferentiate to mucin-secreting goblet 
cells [24]. These additional goblet cells secrete excessive mucins, which accumulate in the middle ear 
cavity and lead to conductive hearing loss (otitis media). We used Mayer’s mucicarmine staining to 
detect the density of goblet cells in the asj mutant mice. Already at two weeks of age, an excess of 
goblet cells was observed around the opening of the Eustachian tube and in the Eustachian tube duct of 
mutant mice (Figure 1.4B).  
In the control mice, scattered goblet cells were seen around the opening of the Eustachian tube, but 
very few were detected along the Eustachian tube duct (Figure 1.4A). Similar observations were made in 
two-month-old adult mice: more goblet cells were present in the epithelia lining the middle ear cavity 
and the Eustachian tube in mutants (Figure 1.4D) than in controls (Figure 1.4C).   
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1.3.2.3 Impaired Eustachian tube function due to epithelia proliferation.  
 Out of 10 ear preparations (8-30 weeks) that allowed us to observe the opening of the 
Eustachian tube in the middle ear cavity, 7 had amorphous tissues that could potentially block the 
Eustachian tube (Table 1.3) thereby disrupting middle ear pressure regulation and ciliary clearance of 
secretions.  
 
Figure 1.4 Increased density of goblet cells in Enpp1asj/asj mice. 
Mayer's mucincarmine method was used to visualize goblet cells (stained red) in the epithelia lining 
the Eustachian tube (A, B) and middle ear cavity (C, D) of mutant and control mice. A, B: Few goblet 
cells are seen in the epithelia lining the Eustachian tube of littermate control mice (A, empty arrow 
points to Eustachian tube, insert shows higher magnification of the Eustachian tube epithelia). By 
contrast, goblet cells are present at high density in the epithelium lining the Eustachian tube of 
Enpp1asj mutant mice (B, empty arrow points to Eustachian tube, magnified inset shows goblet cells, 
marked by arrows, in the Eustachian tube epithelia). C, D: More goblet cells are present in the 
epithelia in the middle ear cavity (MEC) of the asj mutant mouse (arrows in D) than in the control (C). 
Scale bars: A, B = 200 μm, C, D = 50 μm, A and B inserts = 20 μm. 
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1.3.2.4 Impaired middle ear epithelial clearance function due to excess mucin and loss of microciliary 
function.  
Using scanning electron microscopy (Fig. 1.5), we assessed the integrity of the mucociliary epithelium in 
1-month-old and 6-month-old wild-type and Enpp1asj/asj mice (n= 3 each genotype). The epithelium of 
one-month-old mutant mice had scattered areas with high densities of goblet cells (Figure 1.5B), which 
was confirmed by Mayer’s mucincarmine staining. Goblet cell density in 6-month-old mutants could not 
be determined because of the obscuring layer of mucin (Figure 1.5D). These results indicate that 
excessive mucin secreted by increased numbers of goblet cells and the hindering effect of the mucin 
layer on ciliary function in the asj mutant mice are contributing factors to the occurrence of otitis media. 
 
 
Figure 1.5 Scanning electron micrographs of epithelium lining the middle ear cavity 
Compared with littermate controls (A), the middle ear epithelium in 1-month-old Enpp1asj mutant mice (B) 
shows an increased number of goblet cells (red asterisks). Scattered goblet cells (green asterisks) and cilia are 
seen in the mucociliary epithelia of control mice at 6-months of age (C); however, a layer of mucin obscures 
most cilia and goblet cells (arrows) in age-matched Enpp1asj mutant mice (D). Scale bars = 25μm. 
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1.3.3 Over-calcification of middle ear structures (tympanosclerosis) 
 6-month old control mice have transparent tympanic membrane (Figure 1.6A), mutant mice at 
the same age have retracted tympanic membrane due to the pressure of excessive discharge and white 
patch were observed at pars tensa of tympanic membrane in the mutant mice (Figure 1.6B). We 
dissected middle ear ossicles of 6-month-old Enpp1asj/asj mice with littermate controls. Control mice have 
normal morphology of ossicles (Figure 1.6C). We found that stapes in the mutant mice have normal 
morphology and are freely removable from the round window (Figure 1.6D). Although malleus an incus 
has relative normal morphology, these two bones are fused (Figure 1.6D). The wall of the stapedial 
artery, which passes through the ring of the stapes, is thicker in Enpp1asj mutant mice (Figure 1.2F) than 
controls (Figure 1.2E). Alarin red staining indicates excessive calcium deposition in the artery wall of the 
mutant mice (Figure 1.6F). Therefore, enlarged and stiffened stapedial artery could potentially impede 
the movement of the stapes and lead to impaired sound transmission to the inner ear. We observed 
overossification of round window ridge in the mutant mice (Fig. 1.2B, Table 1.3), which may indirectly 
contribute to otitis media and hearing loss. We observed that the round window membrane in Enpp1asj 
mutant mice (Figure 1.3H) was thicker than in control mice (Figure 1.3G).  
 
 
16 
 
 
 
 
Figure 1.6 Calcification of middle ear structures (or tympanosclerosis) in Enpp1asj/asj mice 
In the control mice (A), the outer ear canal is clear without any discharge. The tympanic membrane appears to 
be transparent and malleus (blue asterisk) is clearly visible. In the age matched mutant mice (B), surrounding 
bone must be removed to expose the tympanic membrane, most of which is completely covered by discharge. 
White patches (inside black dashed lines) were observed on the tympanic membrane of the mutant mice (B). 
The ossicle bones of the age matched control and mutant mice appear to have similar morphology (C-D), but 
malleus and incus are fused in the mutant mice (D, red arrow). M: Malleus; I: Incus; S: Stapes. Alizarin red 
staining reveals extensive mineralization in the stapedial artery wall (green asterisk) in Enpp1as/asjj mice (F), but 
not in the control mice (E). 
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1.3.4 Bacterial infection does not play a role in the development of otitis media in Enpp1asj/asj mice 
 The effusion was confined within the middle ear cavity and did not appear to extend through 
the round window into the inner ear. To detect if otitis media in the asj mutant mice was caused by 
bacterial infection, we performed gram staining in the freshly prepared middle ear sections. We failed to 
detect any pathogens from the middle ear cavities of the asj mutant mice (data not shown), suggesting a 
non-infection origin of the otitis media in the asj mutant mice.  
1.4 Discussion 
1.4.1 Otitis media-related ear pathology of Enpp1asj mutant mice 
 Beginning at 6 weeks of age, an effusion starts to appear in the middle ears of asj mutant mice, 
and moderate epithelial proliferation is observed lining the middle ear cavity. The degree of middle ear 
effusion and epithelial thickening in asj mutant mice correlates with ABR thresholds. At 12 weeks of age 
the content of the effusion changes from serous to suppurative, with a corresponding increase in ABR 
thresholds. These effusions in the middle ear cavity may interfere with the normal vibration of the 
tympanic membrane and movement of the ossicle chain; with suppurative effusion having a much 
stronger effect. We observed discharge in the outer ear cavity starting around 4 months of age. All of 
the ears examined from seven 6~7-month-old asj mutant mice showed complete blockage of the outer 
ear canal by discharge, which could explain the secondary increase in ABR thresholds that occurs in asj 
mutant mice between 12 and 18 weeks of age.  
 Mucins are secreted by goblet cells that lay scattered in the epithelium of digestive, respiratory, 
urinary, and reproductive tracts either at a basal level or at a high level upon stimulation [25]. Mucins, 
together with the cilia that line the epithelia, protect the host by cleaning invading pathogens. A similar 
mechanism is applied by the middle ear mucociliary system to clear middle ear effusions [24]. Disturbed 
phosphate homeostasis can cause systematic inflammation. Inflammation within the middle ear cavity 
triggers secretion of mucin into the middle ear cavity and transdifferentiation of more epithelial cells 
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into goblet cells, which lead to excessive effusion accumulation in the middle ear cavity. Continued 
chronic middle ear inflammation leads to tissue destruction and fibrosis. Thickened middle ear epithelia 
or fibrosis of epithelia, especially the epithelia around the opening of the Eustachian tube in the middle 
ear cavity can block the Eustachian tube and facilitate effusion accumulation. Although we don’t have 
supporting evidence, excessive discharge in the outer ear canal might be caused by inflammation in the 
external ear. Defective action of the cilia lining the middle ear epithelia is often associated with 
development of otitis media, as seen in patients with primary ciliary dyskinesia (PCD) [26]. Impaired 
mucociliary function and increased number of goblet cells in the middle ear cavity of the asj mutant 
mice, confirmed by SEM and Mayer’s mucicarmine staining, indicate that the middle ears of the asj 
mutant mice cannot maintain their ability to clear effusion, which therefore leads to conductive hearing 
loss. Overall, middle ear inflammation with effusion, amorphous tissue mass in the middle ear cavity, 
excessive discharge in the outer ear canal, and ectopic mineralization contribute to the conductive 
hearing loss in the asj mutant mice.  
1.4.2 Mineralization disorders and conductive hearing loss in Enpp1asj/asj mice 
 Mineralization disorders due to abnormal phosphate levels have been associated with 
inflammation in several different diseases, including chronic kidney disease [27, 28] and caridiovascular 
disease [29]. Enpp1asj adds to a growing list of mouse mutations causing phosphate homeostasis 
disorders that have associated conductive hearing loss, including mutations of the Ank, Phex, Rpl38, and 
Fgf23 genes. Ank (progressive ankylosis) encodes a multiple-pass transmembrane protein that regulates 
pyrophosphate levels, and Ank mutant mice were reported to have middle ear ossicle fusions and 
associated conductive hearing loss [30]. ANK mutations in human patients also have been reported with 
associated with conductive hearing loss[31]. PHEX (X-linked phosphate regulating endopeptidase) is an 
enzyme that is involved in regulating the balance of phosphate in the body. PHEX mutations are 
associated with X-linked hypophosphatemic rickets in human patients, with hearing loss as one of the 
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symptoms[32-34]. Mice with Phex mutations exhibit hypophospatemia-related abnormalities and 
hearing impairment[35], which recently was shown to be associated with middle ear effusion and ciliary 
defects[8]. Rpl38 (ribosomal protein L38) is not known to be directly involved in phosphate regulation; 
however, elevated organic phosphate levels in Rpl38Ts mutant mice[4]  suggest a potential but unknown 
function of Rpl38 in phosphate homeostasis. Rpl38Ts mutant mice have conductive hearing loss caused 
by ectopic ossification and cholesterol crystal deposition in the middle ear cavity, enlarged Eustachian 
tube, and chronic inflammation with effusion[4].  FGF23 (fibroblast growth factor 23) is a circulating 
hormone that controls phosphate and calcium homeostasis and bone mineralization. Abnormal serum 
levels of FGF23 lead to systemic pathologies in humans, including renal phosphate wasting diseases and 
hyperphosphatemia. FGF23-deficient mice show a mixed hearing loss and middle ear 
malformations[36], and changes in circulating FGF23 have been observed in humans and mice with 
ENPP1 and PHEX deficiencies[16, 37].  
 ENPP1 produces inorganic pyrophosphate (PPi), an inhibitor of mineralization. Because PPi 
levels are markedly reduced in Enpp1asj/asj mice[13], it is not surprising to see ectopic mineralization and 
calcification of middle ear tissues, as was observed in other soft tissues of these mutant mice[13]. 
Calcification of soft tissues within the middle ear cavity could contribute in various ways to the 
conductive hearing loss of Enpp1asj/asj mice. The stapedial artery is an embryonic artery that disappears 
at the early embryo stage in humans but is conserved in mice through adult ages [38]. We observed a 
thickened stapedial artery wall in Enpp1asj mutant mice, which is likely due to calcification as has been 
observed in other soft tissues. The thicker arterial wall is not likely to affect transport function, but 
because the artery passes through the ring of the stapes, its thickened wall could potentially impede the 
vibration of the stapes and contribute to the conductive hearing loss of mutant mice.  
 Abnormal mineralization can also cause otosclerosis and tympanosclerosis, two conditions that 
commonly lead to hearing loss in human patients. Disruption of bone homeostasis of the otic capsule 
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can lead to otosclerosis [39], and the most common feature of otosclerosis is stapes fixation. Although 
we observed ectopic mineralization and bone deposition in the otic capsule of asj mutant mice starting 
from around 6 weeks of age, stapes fixation is absent from Enpp1 mutant mice. Instead, we observed 
white patch on the tympanic membrane, malleus and incus fusion, which are typical symptoms of 
tympanosclerosis. We observed a thickened round window membrane in Enpp1asj/asj mice at 8 weeks of 
age, which may increase the rigidity of the membrane and impede proper cochlear fluid movement and 
hair cell stimulation [40]. Therefore, Enpp1asj mice can serve as a model for studying tympanosclerosis. 
Decreased PPi levels in Enpp1asj/asj mice also lead to otitis media, perhaps the most important factor 
contributing to the hearing loss, but the underlying mechanism of pathology is uncertain.  ENPP1 
deficiency is known to cause elevated serum levels of FGF23 in Enpp1 mutant mice[16], and excess 
FGF23 secreted in the middle ear may trigger mucoperiosteum proliferation, which may contribute to 
the development of otitis media. In support of this possibility, mucoperiosteum proliferation in 
Enpp1asj/asj mice is remarkably enhanced around the regions of the otic capsule that exhibit ectopic 
mineralization. Enpp1asj mice provide a tool to unravel the underlying mechanism of the development of 
otitis media that is associated with abnormal phosphate homeostasis.  
1.5 Summary 
 This is the first report of hearing loss and ear pathology associated with a mutation of the mouse 
Enpp1 gene.  The conductive hearing loss of Enpp1asj mutant mice provides a new animal model for 
studying otitis media and tympanosclerosis related to mineralization defects. It also provides a specific 
model for understanding the hearing loss recently reported to be a clinical feature associated with 
human ENPP1 mutations[17, 18].  
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CHAPTER 2 HEARING LOSS WITHOUT OVERT METABOLIC ACIDOSIS IN ATP6V1B1 DEFICIENT MRL MICE, 
A NEW GENETIC MODEL FOR NONSYNDROMIC DEAFNESS WITH ENLARGED VESTIBULAR AQUEDUCTS 
2.1 Introduction 
 Many of the transport proteins that are involved in acid secretion and bicarbonate reabsorption 
in the kidney have similar functions in the inner ear [41]. The vacuolar (v)H+-ATPase pump is one of the 
key membrane transporters for acid excretion in the α-intercalated cells of the distal nephron, and it is 
also expressed in the inner ear where it functions in endolymph pH homeostasis [42]. vH+-ATPase is a 
large multi-subunit complex consisting of both cytosolic (V1) and transmembrane (V0) domains. Distal 
renal tubular acidosis (dRTA) caused by vH+-ATPase mutations (OMIM 267300, 602722) is an autosomal 
recessive disorder of renal H+ transport causing a buildup of acid in the bloodstream (metabolic acidosis) 
with associated alkaline urine; it is frequently accompanied by sensorineural hearing loss. dRTA with 
hearing loss is caused by mutations in the ATP6V1B1 gene [42, 43], which encodes the B1 subunit of the 
cytosolic domain of vH+-ATPase, and with mutations in the ATP6V0A4 gene [43, 44], which encodes the 
a4 subunit of the transmembrane domain. In contrast to the ubiquitous expression of most other vH+-
ATPase subunits, expression of the B1 and a4 subunits appears to be primarily restricted to the inner ear 
and kidney, in complexes that mediate H+ transport across the plasma membrane rather than across the 
membranes of intracellular organelles [45]. 
 The Atp6v0a4-/- knockout mouse recapitulates the systemic metabolic acidosis and hearing loss 
phenotype seen in human dRTA patients [46, 47]. In contrast, Atp6v1b1-/- knockout mice exhibit a mild 
compensated acidosis (alkaline urine with impaired handling of an acid load) [48] and have normal 
hearing [49]. A compensatory membrane expression of the vH+-ATPase B2 subunit was proposed as a 
possible explanation for why Atp6v1b1-/- knockout mice under baseline conditions are healthy and do 
not exhibit the overt metabolic acidosis and symptoms (growth retardation, failure to thrive) 
characteristic of dRTA patients with ATP6V1B1 mutations [48]. In support of this hypothesis, B2-
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containing H+-ATPase complexes, which normally localize to intracellular organelles, were shown to 
relocalize to the apical membranes of renal intercalated cells in B1-deficient Atp6v1b1-/- knockout mice 
[50].  
 In the mouse inner ear, Atp6v1b1 expression has been detected in the epithelial cells of the 
endolymphatic sac and duct and in the interdental cell layer of the cochlear spiral limbus [42, 49]. The 
inner ear expression pattern and the deafness that is associated with ATP6V1B1 mutations in human 
dRTA patients suggest that ATP6V1B1 plays an important role in pH balance in the mouse inner ear. The 
surprising finding that Atp6v1b1-/- knockout mice have normal hearing [49], however, implies that 
redundant mechanisms of pH regulation can compensate for the loss of the vH+-ATPase B1 subunit in 
the mouse inner ear. This compensation may come from relocalization of B2-containing vH+-ATPase 
complexes from intracellular to apical membranes as proposed for renal cells, or it may be accomplished 
by other acid-base transporting mechanisms or pH buffering systems in the inner ear.  
 Here, we describe the genetic and phenotypic characterization of a new spontaneous mouse 
mutation of the Atp6v1b1 gene, named vortex (vtx) for the circling behavior that first identified mutant 
mice. Mice homozygous for this recessive mutation exhibit auditory and vestibular dysfunction 
associated with enlarged endolymphatic compartments of their inner ears, phenotypic features that 
were not observed in the previously reported Atp6v1b1-/- knockout mouse [49] but that are similar to 
those of Atp6v0a4-/- knockout mice [46]. Whereas the Atp6v1b1-/- knockout mouse was characterized on 
a primarily C57BL/6 (B6) background with some admixture from 129S1-derived CJ7 ES cells [48], the 
spontaneous Atp6v1b1vtx missense mutation arose on the genetically distinct MRL/MpJ (MRL) strain. We 
show by congenic strain analysis that the differences in inner ear phenotypes between MRL-
Atp6v1b1vtx/vtx and B6(129S1)-Atp6v1b1-/- knockout mice are due to strain background differences and 
not to differences in the natures of their Atp6v1b1 mutations. We exploited these strain-specific 
differences in a linkage backcross to map loci that modify the degree of hearing loss in Atp6v1b1vtx/vtx 
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mice and found statistically significant linkage with Chromosome 13 markers. The results of our studies 
in mice provide insight into the hearing loss variability that is associated with human ATP6V1B1 
mutations and suggest that genetic background effects underlie this variation. Because MRL-
Atp6v1b1vtx/vtx mice exhibit enlargements of the endolymphatic sac and duct in the inner ear but do not 
exhibit the overt metabolic acidosis characteristic of dRTA, they provide a new genetic model for 
nonsyndromic deafness with enlarged vestibular aqueducts (EVA; OMIM 600791). 
2.2 Materials and Methods 
2.2.1 Mice 
 Experimental mice were bred and housed in the Research Animal Facility of the Jackson 
Laboratory in Bar Harbor, Maine. Mice were fed ad libitum with a 6% fat mouse diet. Water bottles were 
changed weekly and filled with acidified (pH 2.5-3.0) water. The light cycle was 12 hours light and 12 
hours dark. Some post-weaning mice were shipped to Washington University in St. Louis, Missouri, for 
additional analyses. All procedures involving the use of experimental mice were approved by the 
Institutional Animal Care and Use Committees at The Jackson Laboratory and Washington University. All 
methods used in the study were performed in accordance with the guidelines and regulations of the U.S. 
National Institutes of Health (NIH) Office of Laboratory Animal Welfare (OLAW) and the Public Health 
Service (PHS) Policy on the Humane Care and Use of Laboratory Animals.  
 The vortex (vtx) mutation arose spontaneously on strain MRL/MpJ-Faslpr/J (JAX Stock #485). The 
Faslpr mutation was subsequently removed from the vtx colony by mating vtx/vtx mice with MRL/MpJ 
(Stock #486) mice and selecting progeny without the Faslpr mutation as founders. The resulting strain is 
designated MRL/MpJ-Atp6v1b1vtx/KjnJ (Stock #21771), here abbreviated MRL-Atp6v1b1vtx. Mutant mice 
(vtx/vtx) can be identified without genotyping by their overt circling and head tilting behaviors, and the 
colony is maintained by mating +/vtx (unaffected) x vtx/vtx (affected) mice. Both female and male 
vtx/vtx mice are fertile and able to breed. 
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 A C57BL/6J (B6) congenic strain carrying the vtx mutation was generated by first mating MRL-
Atp6v1b1vtx/vtx mice with B6 mice to produce F1 hybrids, followed by repeated backcrosses to B6 mice, at 
each generation selecting hybrids heterozygous for the MRL-derived Atp6v1b1vtx mutation (inferred by 
the presence of MRL alleles at flanking markers D6Mit144 and D6Mit29). N10 generation Atp6v1b1+/vtx 
mice were then inbred, and the MRL-derived Atp6v1b1vtx/vtx genotype was verified by DNA sequencing. 
The resulting homozygous congenic strain is designated B6.MRL-Atp6v1b1vtx/KjnJ (Stock #21772), here 
abbreviated B6.MRL-Atp6v1b1vtx. To define the extent of the congenic region, 19 SNP markers along the 
length of Chromosome 6 were genotyped for B6 and MRL alleles, and the 74-84 Mb MRL-derived 
congenic region of B6.MRL-Atp6v1b1vtx was determined to extend from a breakpoint between 
rs13478686 (Chr6: 29,712,455; GRCm38) and rs3023067 (Chr6: 36,019,022) to a breakpoint between 
rs3024107 (Chr 6: 109,859,726) and rs3693392 (Chr 6: 113,320,611).  
2.2.2 Genetic mapping and DNA analysis of the vtx mutation 
 To genetically map the vtx mutation, individual DNA samples from linkage cross mice were 
typed for multiple MIT microsatellite markers located throughout the mouse genome. Previously 
described PCR methods [51] were used to genotype the chromosomal markers, which were then 
analyzed for co-segregation with the mutant phenotype. PCR primer pairs designed to amplify specific 
markers were purchased from Integrated DNA Technologies (Coralville, IA, USA).  
 PCR for comparative DNA analysis between vtx/vtx mutant and control mice was performed 
according to the same conditions as described above for genetic mapping. PCR primers used to identify 
the vtx mutation of the Atp6v1b1 gene for genotyping were 5'- GATCCCCTTCTCCACATCAG -3' (forward) 
and 5'- AGCATGGTCTATGTGCTGGG -3' (reverse). The expected PCR product size (590 bp) was confirmed 
on a 3.5% agarose gel. PCR products then were purified with the QIAquick PCR Purification Kit (Qiagen 
Inc., Valencia, CA), and sequenced on an Applied Biosystems 3700 DNA Sequencer with an optimized Big 
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Dye Terminator Cycle Sequencing method. Typical DNA sequencing results for distinguishing Atp6v1b1 
wildtype and vtx mutant alleles are shown in Fig. 1.2A. 
2.2.3 Auditory brainstem response (ABR) measurements 
 At the Jackson Laboratory, ABR thresholds were measured at 8, 16 and 32 kHz in a sound 
attenuating chamber using the SmartEP auditory evoked potential diagnostic system from Intelligent 
Hearing Systems (IHS, Miami, FL) as described previously [52]. Briefly, mice were anesthetized with 
tribromoethanol (0.2 ml of 20 mg/ml stock per 10 g of body weight, i.p.) and placed on a temperature 
controlled heating pad to maintain body temperature at 37o C.  Three subdermal electrodes, placed at 
the vertex and behind each ear, were used to record brain stem responses to defined tone-bursts (3 ms 
duration. 1.5 ms cosine-gated rise/fall time). The responses were then amplified, filtered (100-3000 Hz) 
and averaged (25 kHz sampling rate, 10 ms analysis window).  Stimulus intensity was initially decreased 
in 10 dB steps until the response began to disappear and then lowered in 5 dB steps; ABR threshold was 
defined as the lowest intensity at which an ABR response could be reliably obtained.  With our testing 
system, average ABR thresholds for normal hearing mice are about 40, 20, and 45 dB SPL for 8, 16 and 
32 kHz stimuli, respectively. Data from ABR tests at the Jackson Laboratory are shown in Figs. 1 and 8. 
At Washington University School of Medicine (WUSM), ABR measurements were performed in a foam-
lined, single-walled soundproof room (IAC).  Animals were anesthetized (80 mg/kg ketamine, 15 mg/kg 
xylazine, IP) and positioned dorsally in a custom head holder.  Core temperature was maintained at 37.5 
± 1.0 oC using a DC electric heating pad in conjunction with a rectal probe (FHC).  Platinum needle 
electrodes (Grass) were inserted subcutaneously just behind the right ear (active), at the vertex 
(reference), and in the back (ground).  Electrodes were connected to a Grass P15 differential amplifier 
(300-3,000 Hz, x100), then to a custom amplifier providing another 1,000X gain, then digitized at 30 kHz 
and visualized using Tucker Davis Technologies (TDT) System 2 hardware and software.  Sine wave 
stimuli having 0.5 ms cos2 rise/fall times and 5.0 ms total duration were also generated and calibrated 
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using TDT System2 hardware and software.  Stimuli were presented free-field using TDT ES-1 speakers 
placed 7.0 cm from the right pinna and calibrated offline using an ACO Pacific 7016 ¼ inch microphone 
placed where the external auditory meatus would normally be.  During ABR tests, tone burst stimuli at 
each frequency and level were presented up to 1,000 times at 20/sec.  The minimum sound pressure 
level (SPL) required for visual detection of ABR Wave I was determined at 5, 10, 20, 28.3, 40 kHz and 
56.6 kHz using a 5 dB minimum step size. Data from ABR tests at WUSM are shown in Fig. 2.6.  
2.2.4 Endocochlear potential (EP) recording 
 EP recordings were performed at WUSM. Using a fine drill, a hole was made in the left cochlear 
capsule directly over scala media of the lower basal turn.  Glass capillary pipettes (40-80 MΩ) filled with 
0.15 M KCl were mounted on a hydraulic microdrive (Frederick Haer) and advanced until a stable 
positive potential was observed that did not change with increased electrode depth.  The signal from the 
recording electrode was led to an AM Systems Model 1600 intracellular amplifier.  
2.2.5 Tissue processing and imaging for histopathology 
 At the end of ABR and EP recordings at WUSM, animals were overdosed and perfused 
transcardially with cold 2.0% paraformaldehyde/2.0% glutaraldehyde in 0.1 M phosphate buffer (pH 
7.4).  Each cochlea was rapidly isolated, immersed in the same fixative, and the stapes was immediately 
removed.  After decalcification in sodium EDTA for 72 hours, cochleae were post-fixed in buffered 1% 
osmium tetroxide, dehydrated in an ascending acetone series, and embedded in Epon.  Cochleae were 
sectioned parallel to the modiolus at 4.0 µm, then stained with toluidine blue for bright field viewing. All 
auditory and vestibular epithelia were examined qualitatively in at least three inner ears (three animals) 
per genotype.  Bright field images used for illustration were obtained on a Zeiss LSM 700 laser scanning 
confocal microscope using ZEN software. 
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2.2.6 Inner ear paint fills and cleared whole mount preparations 
 E15 embryos (MRL-Atp6v1b1vtx/+, n= 5; MRL-Atp6v1b1vtx/vtx, n=6) and P1 mice (MRL-
Atp6v1b1vtx/+, n=7 ; MRL-Atp6v1b1vtx/vtx, n=5) were used for inner ear paint fills. E15 embryos were 
decapitated and whole heads were fixed in Bodian’s fixative. P1 mice were decapitated and half-heads 
were fixed in Bodian’s fixative after the brain was removed. Heads were fixed overnight and then 
dehydrated with 75% ethanol (2x 2 hours), 95% ethanol (2x 2 hours), and 100% ethanol (2x 2 hours). 
Heads were then rinsed once with methyl salicylate and cleared overnight by placing specimens in 
methyl salicylate. Inner ears were filled with 1% Wite-Out correction fluid in methyl salicylate using a 
Hamilton syringe, with a pulled glass capillary needle broken to a tip diameter of 20-40 μm. E15 inner 
ears were injected through the middle turn of the cochlea. Two injections were done for P1 inner ears 
with one injection to the cochlear middle turn and the second injection in the common crus (Kiernan, 
2006). To observe otoconia, inner ears dissected from bisected heads of P1 mice were cleared with 
methyl salicylate as described above, sub-illuminated and photographed using a Leica dissecting 
microscope. 
2.2.7 Blood and urine analysis   
 At 17 weeks of age spot urine and blood were collected from 5 males of each group. 
Immediately after collection, urine pH was measured by using a glass pH electrode (Thermo Orion Micro 
pH Probe). Sodium, potassium, and chloride were measured in urine and blood, calcium and creatinine 
were measured in urine on a Beckman AU680 Chemistry analyzer. Osmolality of blood and urine was 
measured using a 5004 micro-Osmette (Precision Systems). 
2.2.8 Genetic mapping of modifier loci  
 For linkage backcross analysis to map modifier loci, tail-tip samples from individual N2 progeny 
mice were provided to the Jackson Laboratory’s Genotyping Service, which outsources SNP genotyping 
to LGC Genomics (Beverly MA). Each mouse DNA sample was genotyped for 120 selected SNPs that 
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differ between the B6 and MRL strains.  The ABR thresholds of the same backcross mice were evaluated 
as quantitative traits, and the MapManager QTXb20 program of least-squares linear regression [53] was 
used to analyze linkage and identify marker associations with ABR thresholds. 
2.2.9 Analyses of candidate modifier genes 
 DNA and cDNA sequencing of candidate genes was performed on an Applied Biosystems 3700 
DNA Sequencer with an optimized Big Dye Terminator Cycle Sequencing method, and the sequencing 
results were analyzed with Sequencher DNA Sequence Analysis Software (Gene Codes Corporation, Ann 
Arbor, MI, USA).   
For qRT-PCR analysis of candidate gene expression, inner ears were dissected from two-week-old MRL-
Atp6v1b1vtx/vtx, MRL-Atp6v1b1vtx/+, B6.MRL-Atp6v1b1vtx/vtx, and B6 wild-type mice and snap frozen in 
liquid nitrogen. The two inner ears of each mouse were pooled together and homogenized in 1 ml TRIzol 
(Life Technologies) in GentleMACS M-tubes (Miltenyi Biotech) using a GentleMACS dissociator. 
Homogenates were briefly centrifuged to pellet and remove cell debris. Homogenates were phase 
separated in 1/5 volume of chloroform. RNAs were extracted using the MagMAX mirVana Total RNA 
Isolation Kit (Life Technologies) following the manufacturer’s recommendations on the KingFisher Flex 
Purification System (Thermo Fisher Scientific). RNA quantity and quality were assessed using a Nanodrop 
2000 (Thermo Scientific) and Bioanalyzer 2100 (Agilent) respectively. RNA was reverse-transcribed into 
cDNA using 500 ng total RNA and the Superscript IV First-Strand Synthesis System (Thermo Fisher 
Scientific) following the manufacturer’s recommendations. cDNA was diluted 1:5 with RNase-free water, 
and 2  l of was used for quantitative real-time PCR (qPCR) using a standard SYBR green comparative Ct 
template on a Life Technologies ViiA7 qPCR machine.  Primer sequences were 
ATCCTTTTCCTGCGTCTGAC-forward and CTCATGGAGATGGCTGTCAG-reverse (110 bp product) for 
Slc12a7 and AGGTGGTCACCTTCAAATGG-forward and ACCTTGTGGGACAGGTGAAA-reverse (106 bp 
product) for Slc9a3; both primer pairs produced robust single band products on agarose gels. The 
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double delta-Ct method was used to calculate fold changes in expression levels, and statistical analysis 
comparing mean delta Ct values was done with the two-tailed student test.  
2.3 Results  
2.3.1 Genetic mapping of the vtx mutation  
 The vortex (vtx) mutation arose spontaneously in a colony of MRL/MpJ (MRL) mice at The 
Jackson Laboratory. Mice homozygous for vtx are healthy and fertile with normal growth, but they 
exhibit vestibular dysfunction as evidenced by variable head tilting and circling behaviors, and they are 
profoundly hearing impaired as shown by ABR analysis (Fig. 2.1A).  
 
Figure 2.1 ABR thresholds of MRL-vtx/vtx mutant mice and linkage backcross mice 
A. Average ABR thresholds of six (4 female, 2 male) MRL-vtx/vtx mutant mice and ten MRL-+/vtx control mice for 
8, 16, and 32 kHz pure tone stimulus frequencies. All mice were tested between 4 and 6 weeks of age. Error bars 
represent standard deviations. Thresholds were assigned a value of 100 if no ABR was obtained at the maximum 
test stimulus of 100 dB SPL. B. Frequency distribution of 16 kHz ABR thresholds among 101 N2 mice of the (MRL-
vtx/vtx x FVB) x MRL-vtx/vtx backcross. About half of the N2 mice are expected to be genotype +/vtx and half 
vtx/vtx. 
 
 We first attempted to genetically map vtx by generating an intercross of MRL-vtx mice with B6 
mice; however, the cross was terminated because no abnormal vestibular-related behaviors were 
observed in multiple litters of F2 progeny from this cross. A second linkage intercross then was made 
with F1 hybrids between MRL-vtx/vtx mice and FVB/NJ (FVB) strain mice. Although the number of 
mutant (vtx/vtx) F2 progeny from this intercross, identified by their circling behavior and elevated ABR 
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thresholds, was less than expected, 18 were eventually produced and used for a genome-wide linkage 
screen with MIT microsatellite markers that differed in size between MRL and FVB.  Results of this low-
resolution screen indicated linkage of the vtx phenotype with markers D6Mit15 (17% recombination) 
and D6Mit366 (11% recombination) on Chr 6.  
 To verify and refine this linkage association, a backcross of (MRL-vtx/vtx x FVB) F1 hybrids to 
MRL-vtx/vtx mice was used to generate a total of 101 N2 progeny. Presumed genotypes (+/vtx or 
vtx/vtx) of the N2 mice were assigned according to their ABR thresholds. The distribution of ABR 
thresholds among N2 mice was strongly bimodal (Fig. 2.1B) as expected for a primarily monogenic trait. 
About half (59) of the 101 N2 backcross mice had 16 kHz thresholds equal to or less than 30 dB SPL 
(assigned +/vtx genotypes) and about half (42) had thresholds equal to or greater than 40 dB SPL 
(assigned vtx/vtx genotypes). Thresholds for 8 and 32 kHz stimuli were also analyzed to reinforce 
genotype assignments. The wide range of ABR thresholds among N2 mice in the vtx/vtx category (Fig. 
2.1B) suggests the influence of strain-specific modifiers, which may explain why so few mutant 
phenotypes were observed in progeny from the (MRL x FVB)-+/vtx intercross. The N2 mice then were 
genotyped for multiple polymorphic SNP markers on Chr 6, and haplotype analysis refined the vtx 
candidate region to the interval between rs13478778 (Chr6: 58,317,346 bp; GRCm38) and rs3708822 
(Chr6: 89,292,518 bp).  
2.3.2 Gene identification and molecular characterization of the vtx mutation 
 The 31 Mb candidate region for the vtx mutation contains the Atp6v1b1 gene (Chr6: 83,742,990 
bp-83,758,855 bp), which encodes the B1 subunit of the vacuolar H+-ATPase. We considered Atp6v1b1 a 
good candidate gene for the vtx mutation because (1) it is expressed in the inner ear, (2) mutations of 
the human ATP6V1B1 and ATP6V0A4 genes cause dRTA and deafness, and (3) the inner ear phenotype 
of vtx/vtx mutant mice is similar to that of Atp6v0a4 knockout mice [46, 47]. The genomic DNA 
sequences of all 14 Atp6v1b1 exons and their flanking splice sites in MRL-vtx/vtx mutant mice were 
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compared with those of MRL wildtype controls and revealed a single base pair mutation in exon 3 
(c.233G>A) that changes the codon for glycine (GGC) to a codon for aspartic acid (GAC) at amino acid 
position 78 (p.G78D) of the mouse protein (Fig. 2.2). DNA sequence analysis of exon 3 in additional 
mutant and non-mutant mice confirmed this variant to be the recessive Atp6v1b1vtx mutation. The vtx 
missense mutation occurs in the N-terminal domain of ATP6V1B1 (InterPro: IPR004100). 
 
Figure 2.2 Molecular characterization and consequences of the Atp6v1b1vtx mutation 
A. DNA sequence chromatograms illustrating the G>A nucleotide change (indicated by red arrow) caused by the 
vtx mutation. B. DNA sequence of Atp6v1b1 exon 3 with encoded amino acids shown below in blue font. The G 
nucleotide that is altered in the vtx mutation (shown in red) is part of the GGC codon (boldface, boxed) for glycine. 
The G>A nucleotide substitution at coding DNA position 233 (c.233G>A) causes a glycine to aspartic acid amino 
acid change at position 78 of the ATP6V1B1 protein (p.Gly78Asp). C. Schematic diagram of the ATP6V1B1 protein 
showing the regions encoded by exons 1-14 in alternating light and dark purple shades and locations of the three 
functional domains relative to the amino acid numbers shown below. The vtx mutation is in exon 3, which encodes 
part of the N-terminal domain of the protein. 
 
 The early onset, profound hearing impairment of Atp6v1b1vtxvtx mice on the MRL strain 
background (Fig.2.1A) is strikingly different from the previously reported normal auditory phenotype of 
Atp6v1b1-/- knockout mice on a mixed B6/129S1 strain background [49]. To specifically test for MRL 
versus B6 strain background effects on the mutant phenotype, we generated B6.MRL-Atp6v1b1vtx/vtx 
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congenic mice (described in Materials and Methods) and compared their inner ear and kidney 
phenotypes with those of MRL-Atp6v1b1vtx/vtx mice. 
2.3.3 Inner ear morphology and auditory function 
 Paintfills of the membranous labyrinths of inner ears from MRL-Atp6v1b1vtx/vtx mutants and 
controls were examined in day 15 embryos (E15) and in newborn (P1) mice. Already at E15, the 
membranous labyrinth of MRL-Atp6v1b1vtx/vtx embryos appeared dilated compared with inner ears of 
MRL-Atp6v1b1+/vtx littermate controls. The swelling was especially apparent in the endolymphatic sac 
and duct, but also noticeable in the utricle, saccule, and cochlear duct  (Fig. 2.3A). The enlargement of 
the membranous labyrinth in inner ears of MRL-Atp6v1b1vtx/vtx mutant mice became even more 
pronounced at P1 (Fig. 2.3B). Cleared whole-mount preparations of inner ears from newborn MRL-
Atp6v1b1vtx/vtx mice showed an obvious enlargement of the cochlear duct but also showed a conspicuous 
deficiency and dispersion of utricular and saccular otoconia compared with MRL-Atp6v1b1+/vtx littermate 
control mice (Fig. 2.3C). Whole mount preparations of inner ears from B6.MRL- Atp6v1b1vtx/vtx mice 
showed normal morphology (not shown).  
 Cross-sections of plastic-embedded adult (2.5-4.5 months-of-age) cochleae (Fig. 2.4) revealed 
wholesale differences in the arrangement of cochlear fluid spaces in B6.MRL-Atp6v1b1vtx/vtx and MRL-
Atp6v1b1vtx/vtx mutant mice.  In the MRL-Atp6v1b1vtx/vtx mutants, scala media appeared reduced in size in 
the lower basal turn, but expanded elsewhere.  Scala vestibuli was generally expanded at the expense of 
scala tympani.  The spiral limbus was widened laterally and contained few fibrocytes.  Spiral ligament 
and stria vascularis were generally thinner, and strial layer structure was disorganized.  In the ligament, 
type I and III fibrocytes were almost entirely missing behind the stria.  Most noteworthy was an absence 
of the boney turn boundary between the lower cochlear base and lower apical turn.  The boundary 
appeared fused with the osseous spiral lamina of the adjacent cochlear regions (not shown).  Few hair 
cells were in evidence in any of the MRL-Atp6v1b1vtx/vtx mutant cochleae examined.  The abnormal 
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Figure 2.3 Paint fills and whole mounts of inner ears from MRL-Atp6v1b1vtx/vtx mutant and control mice 
A. Paint fills of the membranous labyrinths of inner ears from an E15-stage MRL-Atp6v1b1+/vtx (control) embryo 
and two littermate MRL-Atp6v1b1vtx/vtx (mutant) embryos. The endolymphatic sac (es), endolymphatic duct 
(ed), utricle (u), saccule (s), and cochlear duct (cd) appear enlarged in the two mutant inner ears compared 
with the control. B. Paint fills of the membranous labyrinths of inner ears from a newborn (P1) MRL-
Atp6v1b1+/vtx (control) mouse and two MRL-Atp6v1b1vtx/vtx (mutant) littermates. The entire membranous 
labyrinth of the mutant inner ears appears swollen from an excess of endolymph. Other structures labeled in 
the control inner ears of A and B: anterior semicircular canal (asc), posterior semicircular canal (psc), lateral 
semicircular canal (lc), anterior ampulla (aa), posterior ampulla (pa), lateral ampulla (la), common crus (cc). C. 
Cleared, whole-mount preparations of both inner ears from a P1 Atp6v1b1+/vtx newborn mouse (control) and 
two MRL-Atp6v1b1vtx/vtx (mutant) littermates, illuminated from below. Dark-appearing otoconia in the utricle 
(u) and saccule (s) are clearly visible in the control ear, but only a few widely dispersed otoconial crystals are 
seen in the mutant inner ears. The cochlear ducts (cd) of the mutant inner ears are enlarged compared with 
the control. Scale bars for A, B, C: 0.5 mm.  
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Figure 2.4 Cross sections of cochleae from B6.MRL-Atp6v1b1vtx/vtx and MRL-Atp6v1b1vtx/vtx mice 
 
A,B. Whole cochlear profiles from B6.MRL-Atp6v1b1vtx/vtx (A) and MRL-Atp6v1b1vtx/vtx mice (B) imaged at the 
same magnification.  B6.MRL-Atp6v1b1vtx/vtx mutants appear normal while MRL-Atp6v1b1vtx/vtx mutants feature 
greatly reduced scala tympani (compare areas marked with *), missing turn boundary between lower base and 
lower apex (compare areas marked with white arrows), and partial collapse of Reissner’s membrane in the 
lower base (compare black arrows).  C,D. Upper basal turn scala media profiles from different specimens of 
B6.MRL-Atp6v1b1vtx/vtx (C) and MRL-Atp6v1b1vtx/vtx mice (D) imaged at the same magnification.  B6.MRL-
Atp6v1b1vtx/vtx mutants appear normal while MRL-Atp6v1b1vtx/vtx mutants show widened profile, elongated and 
acellular spiral limbus, hair cell loss (see E,F), and lateral wall degeneration (see G). E,F. Enlarged views of organ 
of Corti from C,D show hair cell loss in MRL-Atp6v1b1vtx/vtx mutants (black arrows). G. Enlarged view of MRL-
Atp6v1b1vtx/vtx mutant stria vascularis from D shows thin and disorganized stria and near absence of type I and 
III fibrocytes (white arrow).  Scale bar in A applies to B.  All other scale bars 20 µm.  LB: Lower base; UB: Upper 
base; LA: Lower apex; UA: Upper apex; RWM: Round window membrane; Sp Lim: Spiral Limbus; Sp Lig: Spiral 
ligament; RM: Reissner’s membrane; StV: Stria vascularis; I, II, III, IV:  Fibrocyte types by area; OC: Organ of 
Corti; IP: Inner pillar; OP: Outer pillar; DC: Deiters’ cells; IHC: Inner hair cell; OHC: Outer hair cell.  
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appearance of the lateral wall and absence of hair cells are consistent the complete absence of tone 
responses in these animals. 
    Comparison of the vestibular organs by genotype (Fig. 2.5) indicated little hair cell or neural loss 
in any group.  MRL-Atp6v1b1vtx/vtx mutant cristae were similar to those of the B6.MRL-Atp6v1b1vtx/vtx 
mutants in normal appearance, including the presence of a cupula and complement of dark cells.  The 
appearance of all maculae was likewise similar by genotype with respect to hair cells.  What 
  
Figure 2.5 Cross sections of vestibular organs from B6.MRL-Atp6v1b1vtx/vtx and MRL-Atp6v1b1vtx/vtx mice 
 
A,B. Both B6.MRL-Atp6v1b1vtx/vtx (A) and MRL-Atp6v1b1vtx/vtx (B) mutant cristae appeared normal (posterior 
cristae is shown), including presence of cupula, hair cells, and dark cells. C-F. B6.MRL-Atp6v1b1vtx/vtx maculae 
(saccule shown in C) appeared normal.  MRL-Atp6v1b1vtx/vtx mutant maculae (saccule is shown in D-F) showed 
normal complement of hair cells, but few, very large otoconia that tended toward triangular shapes.  
Macrophages (arrows in D) often lined the epithelial surface and surrounded abnormal otoconia.  Scale bar in 
A applies to all panels.  Cup: Cupula; HC: Hair cells; DC: Dark cells; Ot: Otoconia.   
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distinguished MRL-Atp6v1b1vtx/vtx mutant maculae was the frequent presence of macrophages lining the 
epithelium, contrasted with the complete absence of normal otoconia.  Instead, the MRL-Atp6v1b1vtx/vtx 
mutants featured very few, very large otoconia that tended toward triangular shapes.  These also were 
often associated with macrophages.  Based on appearance, it is possible that MRL-Atp6v1b1vtx/vtx mutant 
cristae function normally if K+ levels are normal, since the endocochlear potential (EP) is normally low in 
the vestibular organs.  The maculae, however, may be aberrantly responsive or unresponsive due to the 
lack of normal otoconia, despite little apparent hair cell loss. 
 ABR thresholds of adult mice (2.5 and 4.5 months of age) were compared for 5, 10, 20, 28.3, 40, 
and 56.6 kHz test stimuli (Fig. 2.6A). Thresholds of B6.MRL-Atp6v1b1vtx/vtx congenic strain mice and MRL-
Atp6v1b1+/vtx control mice were similar and in the normal range for most inbred mouse strains. MRL-
Atp6v1b1vtx/vtx mice, however, failed to elicit an ABR even at the maximum test stimulus (100 dB SPL) for 
any of the test frequencies, indicating complete deafness. Likewise, EP measurements were normal in 
 
Figure 2.6 ABR and EP measurements of auditory function in B6.MRL-Atp6v1b1vtx/vtx and MRL-Atp6v1b1vtx/vtx 
mice 
 
A. Average ABR thresholds of MRL-Atp6v1b1vtx/vtx mice (MRL-vtx/vtx; 4 females, 6 males); MRL-Atp6v1b1+/vtx 
mice (MRL-+/vtx; 3 females, 5 males); and B6.MRL-Atp6v1b1vtx/vtx mice (B6.MRL-vtx/vtx; 5 females, 5 males). 
Thresholds were obtained from 5, 10, 20, 28.3, 40, and 56.6 kHz pure tone test frequencies. Thresholds were 
assigned a value of 100 if no ABR was obtained at the maximum test stimulus of 100 db SPL. Mice were tested 
between 2.5 and 4.5 months of age. Bars represent standard errors of the means. B. Enodocochlear potential 
(EP) measurements (mV) of the same mice were obtained immediately after the ABR tests. EP values are 
shown for individual mice. 
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B6.MRL-Atp6v1b1vtx/vtx and MRL-Atp6v1b1+/vtx mice but nearly absent in MRL-Atp6v1b1vtx/vtx mice (Fig. 
2.6B).  These results clearly demonstrate that the MRL strain background has a strong deleterious effect 
on the auditory phenotype of Atp6v1b1vtx/vtx mutant mice. 
2.3.4 Kidney-related phenotype 
 MRL-Atp6v1b1vtx/vtx and B6.MRL-Atp6v1b1vtx/vtx mice were healthy and showed no overt 
symptoms of metabolic acidosis. The previously reported B6(129S1)-Atp6v1b1 knockout mice show 
increased urine pH, decreased calcium excretion, and decreased osmolality (9). We measured these 
characteristics in the MRL-Atp6v1b1vtx/vtx and B6.MRL-Atp6v1b1vtx/vtx mice and compared them with 
wildtype mice from the same genetic background. Similar to results reported for mice with the 
Atp6v1b1 knockout mutation, mice homozygous for the Atp6v1b1vtx mutation on the B6 background had 
a significantly higher urine pH (6.5 ± 0.1 vs 6.2 ± 0.1) compared to wildtype B6 mice (Figure 2.7A). We 
did not observe a difference between wildtype and Atp6v1b1vtx/vtx mutant mice on the MRL background, 
but wildtype MRL mice had an unusually high urine pH (6.5 ± 0.2) compared to several other strains we 
tested: C57BL/6J (6.2 ± 0.1), A/J (6.1 ± 0.1), 129S1/SvImJ (5.8 ± 0.1), and NOD/LtJ (6.0 ± 0.2).  
 Decreased calcium excretion (urinary Ca2+/Cr mg/g ratios) was observed in mice with the 
Atp6v1b1vtx mutation in both genetic backgrounds (Figure 2.7B) although we saw a larger decrease 
(163.3 ± 17.4 vs. 45.9 ± 6.0l, approx. 70%) in the MRL background compared to the B6 background 
(139.2 ± 9.1 vs. 99.0 ± 9.6, approx. 30%). We did not measure a significant effect of the Atp6v1b1vtx 
mutation on osmolality on either background. In addition, we also measured potassium, sodium, and 
chloride concentrations in both blood and urine and did not find any significant differences between 
Atp6v1b1vtx/vtx and wildtype mice on either strain background (Table 2.1). 
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Figure 2.7  Renal secretion in B6- and MRL-Atp6v1b1vtx mutant mice at 17 weeks of age 
A. Urine pH is significantly increased in vtx mice compared to wildtype controls in the B6 background, but not 
in the MRL background. Urine pH of MRL+/+ mice is significantly higher than that of B6+/+ mice and similar to 
that of vtx/vtx mutant mice on either strain background. B. Calcium excretion is decreased in the mutant mice 
for both genetic backgrounds, but with a much larger decrease in MRL. Values are expressed as mean ± SE and 
each group contained 5 male mice. 
Table 2.1 Physiological parameters of Atp6v1b1vtx/vtx (vtx/vtx) and Atp6v1b1+/+ (+/+) control mice 
on the MRL and B6 strain backgrounds.   
 MRL B6 
 +/+ vtx/vtx +/+ vtx/vtx 
Blood     
Na+, mM 156.4 ± 0.7 155.3 ± 1.0 151.5 ± 1.5 154.1 ± 0.9 
K+, mM 5.6 ± 0.1 6.6 ± 0.7 5.2 ± 0.2 5.9 ± 0.4 
Cl-, mM 104.4 ± 0.6 106.4 ± 1.2 110.1 ± 0.8 109.7 ± 0.7 
Osm, mmol/kg 326 ± 3 323 ± 3 328 ± 2 320 ± 2 
Urine     
Na+, mM 173.2 ± 42.1 142.8 ± 22.6 152.0 ± 15.8 154.6 ± 27.5 
K+, mM 155.9 ± 27.7 136.4 ± 9.0 166.6 ± 16.5 157.4 ± 5.4 
Cl-, mM 155.3 ± 34.6 134.5 ± 14.2 177.4 ± 19.6 167.4 ± 21.7 
Osm, mmol/kg 993 ± 106 896 ± 139 1,026 ± 185 1,069 ± 254 
There were no statistically significant differences between mutant and wildtype mice from the same genetic 
background. Values are mean ± SE. The number of male mice in each group is 5. 
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2.3.5 Genetic mapping of hearing loss modifiers 
 
 To genetically map loci that contribute to hearing loss differences between B6.MRL-
Atp6v1b1vtx/vtx and MRL-Atp6v1b1vtx/vtx mutant mice, we first generated F1 hybrids between these two 
strains. The F1 hybrid mice are homozygous for the vtx mutation and for MRL alleles at linked loci within 
the congenic region of the B6.MRL-Atp6v1b1vtx/vtx strain, and heterozygous for B6 and MRL alleles 
elsewhere in the genome. ABR thresholds of 6-week-old F1 hybrids are very similar to those of 8-week-
old B6.MRL-Atp6v1b1vtx/vtx congenic mice and much lower than those of 5-week-old MRL-Atp6v1b1vtx/vtx 
mice (Fig 8A), indicating that B6-derived alleles at loci outside of the congenic region have a mostly 
dominant effect in preventing hearing loss. To reveal the phenotype of recessive MRL-derived, hearing 
loss-promoting alleles and reduce genetic complexity for mapping, the F1 hybrids were backcrossed to 
MRL-Atp6v1b1vtx/vtx mice rather than intercrossed.  We use the notation (MRL-vtx/vtx x B6.MRL-vtx/vtx) 
x MRL-vtx/vtx to represent this backcross. N2 progeny from this backcross are homozygous for the 
Atp6v1b1vtx mutation and for MRL-derived alleles at linked loci within the congenic region, but are either 
homozygous for MRL alleles (M/M) or heterozygous for B6 and MRL alleles (B/M) at all other loci 
throughout the genome. ABR thresholds of the N2 backcross mice showed a broad, non-bimodal 
frequency distribution (Fig. 2.8B) suggesting that modifier effects on hearing loss are derived from 
multiple loci rather than a single locus with a large effect. 
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 We next performed a genome-wide linkage analysis of the N2 mice of the (MRL-vtx/vtx x B6.MRL-
vtx/vtx) x MRL-vtx/vtx backcross. Out of a total of 102 N2 mice produced from this backcross (all having 
the Atp6v1b1vtx/vtx genotype), 20 with the lowest and 20 with the highest thresholds were chosen for the 
initial linkage analysis. ABR thresholds were analyzed for their linkage with 120 segregating SNP markers 
strategically located on all chromosomes. ABR thresholds for 8-, 16-, and 32-kHz pure-tone auditory 
stimuli were evaluated as quantitative traits, and the MapManager QTXb20 program of least-squares 
linear regression [53] was used to analyze linkage associations of marker genotypes with ABR 
thresholds. Statistically significant linkage with ABR thresholds was found only for markers on Chr 13, 
with a maximum LOD score of 5.2 (Fig. 2.9A).  
 To verify and refine this linkage, we analyzed all 102 N2 mice for six SNP markers spanning Chr 13 
using an interval mapping approach (Fig. 2.9B). The most likely candidate region for modifier gene(s) on 
this chromosome was found to be between rs3719347 (39.5 Mb position, GRCm38) and rs3023390 (96.7 
Mb), with rs3654821 (63.1 Mb) having the highest association (LOD 5.4 for 16 kHz thresholds). 
 
Figure 2.8 ABR thresholds of parental strains, F1 hybrids, and N2 backcross mice 
A. Average ABR thresholds of MRL-Atp6v1b1+/vtx controls (MRL-+/vtx, N = 11, test age 5 wks); MRL-
Atp6v1b1vtx/vtx mutant mice (MRL-vtx/vtx; N = 6, test age 5 wks); B6.MRL-Atp6v1b1vtx/vtx congenic mice 
(B6.MRL-vtx/vtx; N = 10, test age 8 wks); and MRL-Atp6v1b1vtx/vtx x B6.MRL-Atp6v1b1vtx/vtx F1 hybrid mice 
(N = 33, test age 6 wks). Error bars represent standard deviations of the means. Thresholds were assigned a 
value of 100 if no ABR was obtained at the maximum test stimulus of 100 db SPL. B. Frequency distribution of 
16 kHz ABR thresholds among 102 backcross (N2) mice generated from matings of (MRL-Atp6v1b1vtx/vtx x 
B6.MRL-Atp6v1b1vtx/vtx) F1 hybrids with MRL-Atp6v1b1vtx/vtx mice. All N2 mice (genotype 
Atp6v1b1vtx/vtx) were tested for ABR thresholds at 4-6 weeks of age. The dark colored bars on the ends of 
the distribution indicate 40 N2 mice with the most extreme thresholds, which were used for whole-genome 
linkage analysis to map modifier loci.  
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Figure 2.9 Mapping modifier loci that influence ABR thresholds of Atp6v1b1vtx/vtx mice 
A. Genome-wide linkage associations of chromosomal markers with ABR thresholds. A subset of 40 N2 mice 
with extreme thresholds - 20 N2 mice with the lowest and 20 with the highest - were selected for the initial 
genome linkage screen. Different colors are used to indicate 8 kHz, 16 kHz, and 32 kHz threshold associations 
with marker loci. Horizontal dashed lines mark the minimum LOD score values for suggestive and significant 
linkage. Only markers on Chr 13 showed a significant association with ABR thresholds. B. Linkage associations 
of Chr 13 markers with ABR thresholds of all 102 N2 mice. The effects of a hypothetical QTL were analyzed at 
the position of each marker locus (A-E) and at 1 cM intervals between the marker loci. SNP marker loci and 
their Mb positions on Chr 13 are as follows: (A) rs3701757, 16.2 Mb; (B) rs3719347, 39.5 Mb; (C) rs3654821, 
63.1 Mb; (D) rs3023390, 96.7 Mb; (E) rs3724755, 115.4 Mb. C. Genotype effects of the Chr 13 SNP marker 
rs3654821 on the mean ABR thresholds ( SEM) of the 102 backcross mice. The rs3654821 SNP was the 
marker with the highest linkage association, and variation at this locus can explain about 20% of the total ABR 
threshold variation observed among the 102 N2 mice.  B/M, heterozygous for B6 and MRL alleles (N = 50): 
M/M, homozygous for MRL alleles (N = 52). 
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Segregation at this locus accounts for about 20% of the total threshold variation in the backcross mice. 
Interval mapping in 1 cM increments showed that slightly higher associations (max LOD 6.1) could be 
obtained for hypothetical loci about 8 cM on either side of rs3654821 (Fig. 2.9B). ABR thresholds of 
backcross mice homozygous for MRL-derived alleles (genotype M/M) at the rs3654821 locus were about 
20 dB higher than those of mice heterozygous for B6 and MRL alleles (genotype B/M, Fig. 2.9C). Mean 
thresholds of mice with B/M (N=50) and M/M (N=52) rs3654821 genotypes were statistically 
significantly different at all test frequencies (two-tailed Student’s t-Test probabilities < 0.00001). 
 The most likely location for the Chr 13 modifier of hearing loss in the backcross mice is in the 39.5 
- 96.7 Mb region (Fig. 2.9B). Within this large 57 Mb region, which contains about 400 protein-coding 
genes, we selected two candidates for further testing, Slc9a3 and Slc12a7, because they are expressed 
in the inner ear and are known to be involved in ion homeostasis. Strong expression of the sodium 
hydrogen exchanger NHE3 (the protein encoded by Slc9a3) was demonstrated in the apical membrane 
of strial marginal cells [54], and H+ flux from this exchanger may play a role in controlling acid–base 
balance in cochlear endolymph [55]. A knockout mutation of Slc12a7, which encodes the KCC4 member 
of the K+-Cl- cotransporter family, was shown to cause deafness and renal tubular acidosis; however, the 
endolymphatic compartments of Slc12a7-/- inner ears were not enlarged [56]. We sequenced the 16 
exons of Slc9a3 and the 24 exons of Slc12a7 along with their flanking splice sites in DNA from MRL mice 
and compared them to the reference sequence of the B6 strain, but found no differences except for two 
synonymous SNP variants detected in exons 11 and 13 of Slc9a3, which previously have been identified 
in other inbred strains.  The two candidate genes also were examined by quantitative RT-PCR to 
evaluate and compare their mRNA expression levels in inner ear tissue of MRL and B6 mice at 2 weeks 
of age. We did not detect any differences in expression levels of these genes between MRL and B6 mice 
using the comparative delta-Ct method.  The calculated fold changes (relative to the mean B6 value) in 
Slc12a7 expression were 0.94 (range 0.78-1.13) for MRL and 1.00 (range 0.59-1.68) for B6, and the mean 
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delta Ct values were not significantly different (P=0.81). The calculated fold changes in Slc9a3 expression 
were 1.04 (range 0.77-1.41) for MRL and 1.00, (range 0.82-1.22) for B6, and the mean delta Ct values 
were not significantly different (P=0.87). 
2.4 Discussion 
  The glycine altered by the Atp6v1b1vtx missense mutation is evolutionarily highly conserved, and 
both the SIFT (http://sift.jcvi.org/) and PolyPhen 2 (http://genetics.bwh.harvard.edu/pph2/) computer 
programs predict that the p.G78D substitution is probably damaging to protein function. Patients 
homozygous for a missense mutation of the corresponding amino acid (p.G78R) in the human ATP6V1B1 
protein presented with dRTA and sensorineural hearing loss [57], further verifying the causative nature 
of the mouse Atp6v1b1vtx missense mutation. 
 Evidence from rat kidney cell culture experiments suggests that point mutations in B1 subunits 
may cause dysfunction by inhibiting the normal trafficking of vH+-ATPase to the apical membrane [58].  
If mutant B1 subunits cannot assemble into the native vH+-ATPase complex, they might compete for 
molecules necessary for trafficking of the compensatory B2 subunit to the apical membrane [50]. If so, 
the vtx missense mutation might be more damaging than the knockout mutation, and this may account 
for the phenotypic differences between Atp6v1b1-/- and Atp6v1b1vtx/vtx mutant mice. Alternatively, strain 
background differences may be responsible for their different phenotypes. The Atp6v1b1-/- knockout 
mouse with normal hearing was characterized on a mixed B6/129S1 strain background [48], whereas the 
Atp6v1b1vtx/vtx mutant mouse was initially characterized on an MRL strain background. To directly test 
the effect of strain background on the phenotype of Atp6v1b1vtx/vtx mutant mice, we developed a 
congenic strain in which the MRL-Atp6v1b1vtx mutation was transferred to the B6 background. ABR 
threshold measurements of the resulting B6.MRL-Atp6v1b1vtx/vtx congenic strain mice demonstrated that 
they have normal hearing like B6(129S1)-Atp6v1b1-/- knockout mice. We conclude from these results 
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that strain background differences are responsible for the different auditory phenotypes of MRL-
Atp6v1b1vtx/vtx mice and B6(129S1)-Atp6v1b1-/- knockout mice. 
 The inner ear phenotype of MRL-Atp6v1b1vtx/vtx mice (Figs. 3-5) is very similar to the inner ear 
phenotypes of Atp6v0a4-/- [46], Foxi1-/- [59], and Slc26a4-/- [60] mice; all exhibit increased endolymph 
volume, loss of endocochlear potential, hearing impairment, deficient and abnormal otoconia, and 
vestibular dysfunction. Foxi1 is a forkhead transcription factor that regulates expression of Slc26a4 [59] 
and the Atp6v1b1 and Atp6v0a4 genes encoding vH+-ATPase subunits in the endolymphatic sac (ES) 
epithelia [61]. Mutations of these genes impede fluid absorption in the ES causing endolymph build up 
and dilatation of the membranous labyrinth [62, 63]; however, the molecular mechanisms underlying 
these effects are not fully understood. According to one proposed mechanism [62], mutations of these 
genes reduce the ES epithelium-generated H+ current that normally forces Na+ transport and fluid 
movement out of the ES lumen. The hearing loss, vestibular dysfunction, and other inner ear 
abnormalities of these mutant mice are thought to be consequences of this disrupted fluid homeostasis 
in the ES during embryonic development [63]. 
 Paintfills of the membranous labyrinths of P1 inner ears of MRL-Atp6v1b1vtx/vtx mice (Fig. 2.3B) 
and P0 inner ears of Atp6v0a4-/- mice [46] show a similar morphology with greatly expanded 
endolymphatic sac and cochlear duct. While cochlear cross sections of P0 Atp6v0a4-/- mice show 
expansion of scala media, reduced scala vestibuli, and distended Reissner’s membrane consistent with 
increased endolymph volume, cochlear cross sections of adult (2.5-4.5 month-old) MRL-Atp6v1b1vtx/vtx 
mice (Fig. 2.4) do not show these features, although they do show an overall increase in the dimensions 
of the cochlear capsule. We interpret these differences as a reflection of enlarged capsule formation 
during the period when the membranous labyrinth is in an expanded state (Fig. 2.3B), followed by a 
subsequent reduction in endolymph volume at older ages (after loss of stria vascularus function), 
resulting in reduced size of the scala media and non-distended Reissner’s membrane (Fig. 2.4). 
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 Although MRL-Atp6v1b1vtx/vtx mice have malformed and dysfunctional inner ears, kidney 
dysfunction is minimal (Fig. 2.7; Table 2.1). The mild renal phenotype (compensated acidosis) of MRL-
Atp6v1b1vtx/vtx and B6.MRL-Atp6v1b1vtx/vtx mice is similar to that reported for B6-Atp6v1b1-/- mice [48]. A 
compensatory membrane expression of the B2 subunit of the vH+-ATPase complex was proposed to 
explain why B6-Atp6v1b1-/- mice are healthy and do not exhibit the overt metabolic acidosis 
characteristic of dRTA patients with ATP6V1B1 mutations [48], and this explanation may also apply to 
MRL-Atp6v1b1vtx/vtx and B6.MRL-Atp6v1b1vtx/vtx mice. In contrast, the severe metabolic acidosis reported 
for Atp6v0a4-/- mice [46] may be a consequence of the inability of other vH+-ATPase subunits to 
compensate for the a4 subunit deficiency.  
 Although similar, the urine pH measurements for both the Atp6v1b1vtx/vtx and wildtype mice 
were lower compared to the previously described values by Finberg et al (8). It is important to point out 
that the standard of care at The Jackson Laboratory is to provide mice with acidified (pH 2.5-3.0) water, 
and mice are therefore under an acid load, which might explain the urine pH difference. As previously 
reported for Atp6v1b1 [48] and Atp6v0a4 [47] knockout mice, Atp6v1b1vtx/vtx mice on both the B6 and 
MRL genetic backgrounds are hypocalciuric, which is opposite to the hypercalciuria reported for human 
patients with mutations in these genes [64]. 
 There was no significant difference in urine pH between Atp6v1b1vtx/vtx and wildtype mice on the 
MRL background, but compared to all other strains we measured, MRL wildtype mice have a higher 
urine pH that is comparable to that of Atp6v1b1vtx/vtx mutant mice on either the B6 or MRL background. 
A possible explanation is that the MRL strain has a mutation in a gene involved in the regulation of urine 
pH and that this is epistatic to the Atp6v1b1vtx mutation. If this is indeed the case, then the much larger 
effect of the Atp6v1b1vtx mutation on calcium excretion in the MRL background (70% decrease) 
compared to the B6 background (20% decrease) suggests a synergistic interaction of the mutations on 
this phenotype. 
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 Levels of K+ and Cl- in the blood did not differ between Atp6v1b1vtx/vtx and wildtype mice on 
either the MRL or B6 strain background (Table 2.1), which agrees with the findings for the Atp6v1b1-/- 
knockout mouse with compensated acidosis [48]. In contrast, the Atp6v0a4-/- mouse with severe 
metabolic acidosis has significantly lower concentrations of K+ and Cl- in the blood than controls [47]. 
Although the mild renal phenotype of MRL-Atp6v1b1vtx/vtx mice is similar to that of Atp6v1b1-/- mice, its 
severe inner ear phenotype is similar to that of Atp6v0a4-/- mice. The difference in severity between the 
inner ear and kidney phenotypes of MRL-Atp6v1b1vtx/vtx mice may be due to modifying genetic factors 
that have stronger effects on H+ transport and ion homeostasis in the inner ear than in the kidney 
tubule. Not all cases of dRTA caused by ATP6V1B1 mutations have associated hearing loss [44], which 
lends support to the idea that inner ear and kidney-related pathologies are not always coupled.  
 In an attempt to identify genetic factors that contribute to the different inner ear phenotypes of 
MRL-Atp6v1b1vtx/vtx and B6.MRL-Atp6v1b1vtx/vtx mice, we analyzed ABR threshold associations in a linkage 
backcross involving these two strains. Thresholds of Atp6v1b1vtx/vtx progeny from the backcross showed a 
broad frequency distribution with mostly intermediate values rather than a bimodal distribution with 
two discreet groupings of more extreme values (Fig. 2.8B), indicating contributions from multiple genes. 
A genome-wide linkage screen detected statistically significant associations only with Chr 13 markers 
(Fig. 2.9A), but even the highest association at this locus could account for only about 20% of the total 
ABR threshold variation in the backcross mice. Together, these results suggest a complex genetic basis 
for the difference in MRL and B6 strain background effects on hearing thresholds of Atp6v1b1vtx/vtx mice, 
with multiple contributing genes each having relatively small effects. 
 We examined two interesting candidate modifier genes with known roles in inner ear fluid 
homeostasis (Slc9a3 and Slc12a7) that lie within the candidate region of Chr 13 (39.5 – 96.7 Mb; Fig. 
2.9B), but did not find any differences in the DNA sequences of their exons or in their mRNA expression 
levels in P14 inner ear tissue. Our results, however, do not rule out the possibility that non-coding 
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sequence differences in these genes might cause subtle expression differences during inner ear 
development that we did not detect in two-week-old mice. Of course, one or more of the many other 
genes in the candidate region could also be responsible for the Chr 13 modifier effect. Urine pH and 
calcium excretion were not measured in the linkage backcross mice although they showed significant 
differences between strains and genotypes (Fig. 2.7), and it is possible these differences may co-vary 
with ABR thresholds. If so, then genes located in the Chr 13 candidate region that are not known to 
affect inner ear function but are known to play a role in kidney function, such as Slc34a1, may also be 
considered as candidate modifiers of the Atp6v1b1 phenotype. 
 Our results clearly establish that genetic background differences can have a profound effect on 
the auditory phenotypes associated with Atp6v1b1 mutations in mice and suggest that similar genetic 
background effects could contribute to the phenotypic variability associated with human ATP6V1B1 
mutations. Human cases of dRTA are reported to have variable degrees of inner ear abnormalities [65] 
and hearing loss [44].  Determining the genetic causes underlying the phenotypic differences among 
mouse Atp6v1b1 mutations on different strain backgrounds may shed light on the underlying causes of 
this clinical heterogeneity.  
2.5 Summary 
 Enlargement of the vestibular aqueduct (EVA, OMIM 600791), the bony canal that encloses the 
endolymphatic duct, is a common inner ear malformation diagnosed in children with hearing loss 
(https://www.nidcd.nih.gov/health/enlarged-vestibular-aqueducts-and-childhood-hearing-loss). High 
resolution computed tomography studies have detected bilaterally enlarged vestibular aqueducts in 
patients with autosomal recessive dRTA and deafness [65, 66]. The combination of EVA and hearing loss 
is also characteristic of several other syndromes, including Pendred, branchio-oto-renal, CHARGE, and 
Waardenburg syndromes [67]. Pendred syndrome, caused by mutations of SLC26A4, does not always 
present with thyroid goiter, and these cases constitute the major known underlying cause of 
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nonsyndromic EVA and hearing loss. Because 50% of European or North American Caucasian individuals 
with EVA-associated hearing loss have no obvious SLC26A4 mutations [68], mutations of other as yet 
unidentified genes are thought to be responsible for some of the remaining unknown cases. Variants of 
KCNJ10 and FOXI1 have been proposed to underlie some of these cases [69, 70], but contradictory 
results have been reported in other studies [71-73]. MRL-Atp6v1b1vtx/vtx mutant mice are deaf with 
enlarged endolymphatic compartments of the inner ear but do not recapitulate the overt metabolic 
acidosis characteristic of dRTA. They thus provide a new genetic model for nonsyndromic deafness with 
EVA and suggest that mutations in the human ATP6V1B1 gene might account for some of the unknown 
genetic cases of this disorder that are not associated with SLC26A4 mutations. 
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CHAPTER 3 TBX1 IS REQUIRED FOR SEMICIRCULAR CANAL FORMATION AND STRIA VASCULARIS 
MATURATION 
3.1 Introduction 
 The mammalian inner ear derives from the otic placode, an ectodermal thickening adjacent to 
the hindbrain, formed around embryonic day (E) 8.0. The placode invaginates and forms the otic vesicle 
(otocyst) around E9.5. Starting from E10.5, morphogenesis of the vesicle initiates with endolymphatic 
sac and duct formation from an outgrowth in the dorsal part of the vesicle and cochlear formation from 
an outgrowth in the ventral direction. Vestibular organ formation starts around E11.5, with dorsolateral 
evagination of the otic epithelium to form the ventral canal plate, the precursor of the anterior and 
posterior semicircular canals. Slightly later, the otic epithelium evaginates laterally to form the lateral 
canal plate, the precursor of the lateral semicircular canal. The canals are formed at E12.5 by fusion of 
cells in the vertical plate and the lateral canal plate, followed at E13.5 by resorption of the fused cells 
into the epithelium. During this period, additional evaginations of the central region form the utricle and 
saccule. By E14.5, the inner ear epithelium has acquired its mature morphology[74].  Fully developed 
vestibular organs consist of three semicircular canals, saccule, and utricle, which are important for 
maintaining body balance and sense angular and linear movement. Sensory hair cells in the cristae 
ampullaris of the semicircular canals and maculae of the saccule and utricle detect liquid movement 
within the vestibular portion of the inner ear. Cochlea development occurs slightly later than vestibular 
organ development. Cochlea formation starts from a ventral outgrowth of otic epithelium around E10.5.  
The cochlear duct continues to grow and reaches full length around E18. Tissues and cells within the 
cochlea undergo differentiation and proliferation during this time period and give rise to structures such 
as the organ of Corti, stria vascularis, and spiral ligament. Some tissues continue to develop postnatally. 
For example, hair cell bundles continue to refine their shape and reach the adult-like morphology 
around P15 [75], and interdigitation of intermediate and marginal cells of the stria vascularis fully 
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mature at around P6 [76]. The cochlea within the adult mammalian inner ear is the organ responsible 
for sound perception. Transmission of acoustic waves from middle ear to the cochlea through the oval 
window lead to vibrations of the basilar membrane, and subsequent hair cell depolarization converts 
this mechanical force to a neural impulse that is transmitted to the brain through the acoustic nerve. 
 Endolymph, the liquid within the membranous labyrinth of the inner ear, is critical for normal 
hair cell function. Endolymph is unique in that it contains a very high concentration of K+ and a low 
concentration of Na+, which creates a positive potential of 80-100 mV in the scala media called the 
endocochlear potential (EP). Endocochlear potential provides the major driving force for K+ influx, which 
contributes to the high sensitivity of hair cells to mechanical stimulation. Hair cells, supporting cells 
beneath the hair cells, other epithelial cells on the basilar membrane, and cells of the stria vascularis and 
spiral ligament work together to mediate cochlear K+ circulation. The stria vascularis is essential for 
generating the EP. Genes encoding ion channel and transporter proteins, including KCNJ10, NKCC1, CIC-
K/barttin, and KCNQ1/KCNE1, are expressed in the stria vascularis and mutations in these genes lead to 
reduced or absent EP and hearing impairment in the animal models [77-85].  
 Three layers of cells are found in the stria vascularis (SV). Lining the scala media are the marginal 
cells derived from the otic epithelium; the intermediate cells are specialized melanocyte-like cells 
derived from migratory neural crest cells; and the basal cells are adjacent to the fibrocytes of the spiral 
ligament and are derived from otic mesenchyme. Endodermally derived blood vessels are interspersed 
between these cell layers throughout the SV. The SV continues to develop after birth and reaches 
maturation around P6. This process is majorly completely by interdigitation of marginal cells with 
intermediate cells [76]. The vestibular labyrinth also contains endolymph, although its potential relative 
to body fluid is ~0 mV compared with the 80-100mV EP of the scala media in the cochlea. Ion 
concentrations in the vestibular endolymph are thought to be maintained by “dark cells” in the epithelia 
of semicircular canal ampullae. Dark cells harbor Na+-K+-ATPase, NKCC1, and ClC-K/barttin at their 
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infolded basolateral membrane and express KCNQ1/KCNE1 at the apical membrane. Kcne1, Kcnq1, and 
Slc12a2 knockout mice exhibit a collapse of vestibular endolymphatic space and balance defects in 
addition to cochlear dysfunctions[78-80, 83, 86, 87].  
 Tbx1 belongs to the t-box protein family. T-box proteins are transcription factors that play 
important roles in tissue and organ formation during embryonic development. TBX1 haploinsufficiency is 
associated with human DiGeorge syndrome (DGS = Del22q11.2), which is characterized by 
cardiovascular malformations, hypoplasia or aplasia of the thymus and parathyroid gland, craniofacial 
defects, and hearing impairment. Previous studies have shown that Tbx1 is required for cardiac outflow 
tract morphogenesis [88, 89], pharyngeal apparatus morphogenesis [90, 91], skeletal development [92, 
93], cerebral cortex development [94, 95], and inner ear morphogenesis [96]. Tbx1 null mice are 
embryonic lethal, and inner ear development is stopped at the otocyst stage around E10 [96]. Although 
Tbx1 conditional knockout mice are viable, inner ear development in these mice is also arrested at the 
otocyst stage [97]. Additional studies showed that Tbx1 contributes to inner ear morphogenesis possibly 
through its regulation of cell fate determination [98, 99], cell proliferation[99] and survival [100], neural 
crest migration, and spatial pattern stabilization [101]. Interestingly, a reporter gene study showed that 
Tbx1 is expressed in the stria vascularis and vestibular dark cells at E18.5 [100], suggesting that Tbx1 has 
specific functions in these tissue types. However, because the inner ear does not develop beyond the 
otocyst stage in the null and conditional knockout mice, a new Tbx1 model is required to study Tbx1 
function in the stria vascularis and vestibular organs at later development stages.  
 In this study, we report on a recessive ENU-induced mutation named windmill (wdml) because 
of the circling behavior of homozygous mutant mice. We show that mutant mice are deaf and that wdml 
is a missense mutation of Tbx1. In contrast to previously reported Tbx1 knockout mouse models, 
Tbx1wdml mutant mice are viable with fully formed but abnormal inner ears. They thus provide the first 
model to study the roles of Tbx1 in inner ear development beyond the early otocyst stage. We show that 
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the deafness and vestibular dysfunction in Tbx1wdml mutant mice is due to stria vascularis and 
semicircular canal defects, demonstrating the importance of TBX1 function in the development of these 
inner ear structures.  
3.2 Methods and Materials 
3.2.1 Mice 
 Experimental mice were bred and housed in the Research Animal Facility of the Jackson 
Laboratory in Bar Harbor, Maine. Mice were fed ad libitum with a 6% fat mouse diet. Water bottles were 
changed weekly and filled with acidified (pH 2.5-3.0) water. The light cycle was 12 hours light and 12 
hours dark. All procedures involving the use of experimental mice were approved by the Institutional 
Animal Care and Use Committees at The Jackson Laboratory. All methods used in the study were 
performed in accordance with the guidelines and regulations of the U.S. National Institutes of Health 
(NIH) Office of Laboratory Animal Welfare (OLAW) and the Public Health Service (PHS) Policy on the 
Humane Care and Use of Laboratory Animals.  
 The windmill (wdml) mutation is an ENU induced mutation generated by the Neuroscience 
Mutagenesis Facility at The Jackson Laboratory (JAX) and originally designated nmf219 (Stock #4831). 
The mutant strain is designated C57BL/6J-Tbx1wdml/KjnJ, here abbreviated B6-Tbx1wdml. Mutant mice 
(wdml/wdml) can be identified without genotyping by their overt circling and head tilting behaviors, and 
the colony is maintained by mating +/wdml (female) x wdml/wdml (male) mice.  
3.2.2 Genetic mapping of the wdml mutation 
 The nmf219 (wdml) mutation was originally mapped to the 15913052-32312179 bp position of 
Chr 6 (GRCm38) by the JAX Neuroscience Mutagenesis Facility. To refine this map position, B6-
wdml/wdml mice were crossed to CAST mice, and F1s were intercrossed to produce F2 progeny for 
linkage cross analysis. Individual DNA samples from linkage cross mice were typed for multiple MIT 
microsatellite markers located on Chr 16. Previously described PCR methods (Johnson et al. 2012) were 
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used to genotype the chromosomal markers, which were then analyzed for co-segregation with the 
mutant phenotype. PCR primer pairs designed to amplify specific markers were purchased from 
Integrated DNA Technologies (Coralville, IA, USA). 
3.2.3 Whole-exome sequencing 
 DNA purification, library construction, deep sequencing, and data quality control were 
performed by the Jackson Laboratory’s Next Generation Sequencing service, and data analysis and 
annotation were performed by the Computational Sciences Biostatistics service. Purified genomic DNA 
from wdml/wdml mice and C57BL/6J controls were used to create libraries for whole-exome sequence 
capture. 
3.2.4 DNA sequence confirmation and genotyping of the wdml mutation 
 PCR for comparative DNA analysis between wdml mutant and control mice was performed 
according to the same conditions as described above for genetic mapping. PCR primers used to 
genotype the wdml mutation of the Tbx1 gene were 5′- CGATGTTGCCCTAGGTATGC -3′ (forward) and 5′- 
GGCCTACAACAGGAGACAGC -3′ (reverse). PCR products digested with TaqI restriction enzyme (140 bp 
and 92 bp for the wild-type allele and 232 bp for the wdml allele) were separated on a 3.5 % agarose gel. 
For DNA sequence confirmation of genotypes, PCR products were purified with the QIAquick PCR 
Purification Kit (Qiagen Inc., Valencia, CA), and sequencing was performed using the same primers as for 
DNA amplification, then run on an applied biosystems 3700 DNA Sequencer with an optimized Big Dye 
Terminator Cycle Sequencing method. 
3.2.5 Auditory brainstem response 
 ABR thresholds were measured at 8, 16 and 32 kHz in a sound attenuating chamber using the 
SmartEP auditory evoked potential diagnostic system from Intelligent Hearing Systems (IHS, Miami, FL) 
as described previously [52]. Briefly, mice were anesthetized with tribromoethanol (0.2 ml of 20 mg/ml 
stock per 10 g of body weight, i.p.) and placed on a temperature controlled heating pad to maintain 
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body temperature at 37o C.  Three subdermal electrodes, placed at the vertex and behind each ear, 
were used to record brain stem responses to defined tone-bursts (3 ms duration. 1.5 ms cosine-gated 
rise/fall time). The responses were then amplified, filtered (100-3000 Hz) and averaged (25 kHz sampling 
rate, 10 ms analysis window).  Stimulus intensity was initially decreased in 10 dB steps until the response 
began to disappear and then lowered in 5 dB steps; ABR threshold was defined as the lowest intensity at 
which an ABR response could be reliably obtained.  With our testing system, average ABR thresholds for 
normal hearing mice are about 40, 20, and 45 dB SPL for 8, 16 and 32 kHz stimuli, respectively.  
3.2.6 Histology 
 Histological analyses of the middle and inner ears were performed following the methods 
described previously[20]. Briefly, inner ears from Tbx1wdml/wdml mice and wild-type mice were dissected 
and immersed in Bouin’s fixative and embedded in paraffin. Sections (7 mm) were cut and mounted 
onto Fisher Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA) and counterstained in 
hematoxylin/eosin (H&E). 
3.2.7 Immunofluorescence staining 
 Postnatal mouse inner ears were dissected and fixed in 4% formaldehyde/PBS overnight. Tissues 
were then washed with PBS 3x 5min, rinsed with 10%, 20%, and 30% glucose/PBS solution, frozen in 
Tissue-TekVR O.C.T. compound (Sakura Finetek USA Inc, Torrance, CA, USA) and sectioned at 10 mm. 
Sections were fixed in 4% formaldehyde/PBS for 10 min and permeabilized in 0.2% Triton X-100/PBS for 
5 min. Inner ear sections were subsequently blocked in 3% goat or donkey serum plus 2% BSA in PBS for 
1h, incubated with primary antibodies in the blocking solution at specific dilution ratio at 4C overnight, 
washed several times with PBS and incubated with secondary antibody in blocking solution for for 1h. 
After extensive washes with PBS, the stained inner ear sections were mounted on glass slides using 
ShandonTM Immu-MountTM aqueous non-fluorescing mounting medium (Thermo Electron 
Corporation, Pittsburgh, PA, USA) and imaged using an Olympus FV1000 confocal laser scanning 
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microscope. Primary antibodies used were: KCNQ1 (Santa cruz, cat#: sc-10646, 1:200), KCNJ10 (Alomone 
labs, cat#: apc-035, 1:400), GLUT1 (Santa cruz, cat#: sc-1605, 1:100), secondary antibodies used were 
donkey anti goat cy3 (Abcam, cat#: ab6949, 1:500) and goat anti rabbit Alexa 488 (Invitrogen, cat#: 
A11008, 1:500). 
3.2.8 Inner ear paint fills  
 E14.5 embryos (B6-Tbx1wdml/+, n= 5; B6-Tbx1wdml/wdml, n=6) were used for inner ear paint fills. 
E14.5 embryos were decapitated and whole heads were fixed in Bodian’s fixative. Heads were fixed 
overnight and then dehydrated with 75% ethanol (2x 2 hours), 95% ethanol (2x 2 hours), and 100% 
ethanol (2x 2 hours). Heads were then rinsed once with methyl salicylate and cleared overnight by 
placing specimens in methyl salicylate. A micromanipulator was used to fill inner ears were filled with 
1% Wite-Out correction fluid in methyl salicylate using a Hamilton syringe, with a pulled glass capillary 
needle broken to a tip diameter of 20-40 μm. Inner ears were injected through the middle turn of the 
cochlea.  
3.2.9 RNA-seq 
 Five E16.5 mutant mice and 5 littermate controls were used for the analysis. For each sample, 
RNA was isolated from 2 inner ears using the MagMAX mirVana Total RNA Isolation Kit (ThermoFisher) 
and the KingFisher Flex purification system (ThermoFisher). Tissues were lysed and homogenized in 
TRIzol Reagent (ThermoFisher). After the addition of chloroform, the RNA-containing aqueous layer was 
removed for RNA isolation according to the manufacturer’s protocol, beginning with the RNA bead 
binding step. RNA concentration and quality were assessed using the Nanodrop 2000 
spectrophotometer (Thermo Scientific) and the RNA Total RNA Nano assay (Agilent Technologies). 
Libraries were prepared by the Genome Technologies core facility at The Jackson Laboratory using the 
KAPA mRNA HyperPrep Kit (KAPA Biosystems), according to the manufacturer’s instructions. Briefly, the 
protocol entails isolation of polyA containing mRNA using oligo-dT magnetic beads, RNA fragmentation, 
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first and second strand cDNA synthesis, ligation of Illumina-specific adapters containing a unique 
barcode sequence for each library, and PCR amplification.  Libraries were checked for quality and 
concentration using the DNA 1000 assay (Agilent Technologies) and quantitative PCR (KAPA Biosystems), 
according to the manufacturers’ instructions. Libraries were pooled and sequenced by the Genome 
Technologies core facility at The Jackson Laboratory, 75 bp single-end on the NextSeq 500 (Illumina) 
using NextSeq High Output Kit v2 reagents (Illumina). 
3.2.10 DIG-labeled riboprobes and mRNA in situ hybridization 
 DNA sequences of primers for amplifying Raldh2, Esrrb, Dct are listed in Table 3.1. The sequence 
for the SP6 promoter was added as a 5′overhang to the reverse primer so that the antisense probe could 
be generated directly from the PCR product. A digoxigenin-11-UTP (DIG) labeled antisense riboprobe 
was produced from the purified PCR product by in vitro transcription according to the manufacturer's 
instructions (Roche Applied Science, Indianapolis, IN). 
Table 3.1 Primer sequence for in situ hybridization probes 
Gene 
 
Primer Sequence Reference 
Raldh2 
TAACAATGAATGGCAGAACTCAG 
[102] 
GCGATTTAGGTGACACTATAGGCAATTTTCCAGGTGAACATC 
Esrrb 
TTTGCCTGCTGTTTCTCCTT 
www.eurexpress.org 
GCGATTTAGGTGACACTATAGTGTTTGTCCAACCCTTGCT 
Dct 
AATTCTTCAACCGGACATGC 
Self-designed 
GCGATTTAGGTGACACTATAGGCATCTGTGGAAGGGTTGTT 
  
In situ hybridization was performed as described with the following modifications. Tissue was fixed 
overnight at 4°C in 4% paraformaldehyde. Sections were mounted on Superfrost plus slides (Fisher 
Scientific, Suwanee, GA). Slides were air dried at room temperature for 1–2 hours, followed by fixation 
in 4% parafomaldehyde for 10 minutes. Digestion was carried out for 10 min at room temperature in 
buffer consisting of 50 mM Tris, pH 7.5, 5 mM EDTA, and 1 µg/ml proteinase K followed by fixation in 4% 
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paraformaldehyde for 5 min. Hybridization was performed at 65° C overnight in buffer consisting of 50% 
deionized formamide, 0.3 M NaCl, 20 mM Tris, pH 8.0, 5 mM EDTA, pH 8.0, 10% dextran sulfate, 1× 
Denhardt's solution, 0.5 mg/ml tRNA from baker's yeast (Sigma, St. Louis, MO), and 500 ng/ml of the 
denatured DIG labeled probe. Washes were also carried out at 65° C. Following immunological detection, 
slides were mounted with VECTASHIELD mounting medium (Vector Laboratories, Burlingame, CA). 
3.3 Results 
 In contrast to previously reported Tbx1 knockout and conditional knockout mice, mice 
homozygous for the Tbx1wdml mutation are healthy and fertile with normal growth. Outer, middle, and 
inner ears of Tbx1wdml mutant mice have normal gross morphology at weaning age, but they exhibit 
vestibular dysfunction as evidenced by variable head tilting and circling behaviors, and all mutant mice 
showed profound hearing loss at weaning age (Figure 3.1). 
 
Figure 3.1 Hearing loss in B6-wdml/wdml mutant mice 
Average ABR thresholds of seven B6-wdml/wdml mutant mice and five B6-wdml/+ control mice for 8, 16, and 
32 kHz pure tone stimulus frequencies. All mice were tested between 4 and 6 weeks of age. Error bars represent 
standard deviations. Thresholds were assigned a value of 100 if no ABR was obtained at the maximum test 
stimulus of 100 dB SPL. 
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3.3.1 Genetic mapping of the wdml mutation 
 To refine the map position of the wdml mutation on Chr 16, an intercross of (B6-wdml/wdml x 
CAST/EiJ) F1 hybrids was used to generate a total of 263 mutant (wdml/wdml) F2 progeny. Presumed 
genotypes of the F2 mice were assigned according to their vestibular phenotype (head tilting/circling). 
The F2 mice were then genotyped for Chr 16 MIT microsatellite markers that differed in size between B6 
and CAST, and haplotype analysis narrowed the candidate gene interval to a 2.7 MB region of Chr 16 
(D16Mit143, 18.1 Mb, and D16Mit145, 20.8Mb) containing 54 protein-coding genes. Using high-
throughput, next generation exome sequencing, 15 putative sequence differences in exons were 
identified between B6-wdml/wdml and B6 +/+ control DNA in the 2.7 Mb candidate gene interval. Only 
three of these putative variants had mismatch ratios greater than 0.6, and of these only the Tbx1 variant 
was predicted to have a negative effect on protein function. The mutation discovered in the Tbx1 gene is 
a single base pair change in exon 3 (c.665A>G) that change the codon for aspartic acid (GAC) to a codon 
for glycine (GGC) at amino acid position 212 (p.D212G) of the mouse protein (Figure 3.2).  
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Figure 3.2 Molecular characterization and consequences of the Tbx1wdml mutation 
A. DNA sequence chromatograms illustrating the A>G nucleotide change (indicated by red arrow) caused by the 
wdml mutation. B. DNA sequence of Tbx1 exon 3 with encoded amino acids shown below in blue font. The A 
nucleotide that is altered in the wdml mutation (shown in red) is part of the GAC codon (boldface, boxed) for 
aspartic acid, and also pat of a TaqI restriction enzyme digestion site (TCGA, highlighted in green). The A>G 
nucleotide substitution at coding DNA position 635 (c.635A>G) causes a aspartic acid to glycine amino acid change 
at position 212 of the TBX1 protein (p.Asp212Gly). C. Schematic diagram of the TBX1 protein showing the regions 
encoded by exons 1-7 in alternating purple and organe and locations of the T-box DNA binding domain relative to 
the amino acid numbers shown below. The wdml mutation is in exon 3, which encodes part of the T-box DNA 
binding domain of the protein 
 
3.3.2 Inner ear morphology 
 Cross-sections of paraffin-embedded postnatal cochleae were created to observe cochlear 
structure in the Tbx1 mutant ear and age-matched controls. At P3, mutant Tbx1wdml/wdml cochlea have 
normal-looking endolymph and perilymph compartments; organ of Corti, stria vascularis, and spiral 
ligament appear to be at the right development stage with normal morphology and Reissner’s 
membrane appears at the right location (Figure 3.3).  By P7, mutant mice showed collapsed Reissner’s 
membrane, reduced endolymph volume, and undeveloped stria vascularis. At 5 months of age, mutant 
mice showed a completely collapsed Reissner’s membrane, extremely reduced endolymph volume, and 
The picture can't be displayed.
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a still undeveloped stria vascularis, as well as severe organ of Corti degeneration, which is likely a 
secondary effect of stria vascularis dysfunction.  
 Paintfills of the membranous labyrinths of inner ears from B6-Tbx1wdml/wdml mutants and controls 
were examined in day 14.5 embryos (E14.5). The cochlea of E14.5 mutant mice has an overall normal 
gross morphology; however, there is an obvious malformation of the vestibular apparatus, especially the 
posterior semicircular canal (Figure 3.4). Mutant mice have normal saccule, utricle, and anterior and 
lateral semicircular canals. The posterior semicircular canal and common crus of mutant mice, however, 
are fused into one plate, indicating failure of fusion plate resorption. In addition, the anterior and lateral 
ampullae are not fully separated in the mutant inner ear. 
 
Figure 3.3 Cross-sections of cochleae from Tbx1wdml/wdml and Tbx1wdml/+ mice 
A,B. Whole cochlear profiles from P3 Tbx1wdml/+ (A) and Tbx1wdml/wdml mice (B) imaged at the same magnification.  
Tbx1wdml/wdml mutants appear normal compared to the age-matched Tbx1wdml/+ control mice. C,D. Whole cochlear 
profiles from P7 Tbx1wdml/+ (C) and Tbx1wdml/wdml mice (D) imaged at the same magnification. Tbx1wdml/wdml mutants 
show collapsed ressiner’s membrane (yellow arrowhead), reduced endolymph volume (green asterisk) and smaller 
stria vascularis region (red arrow). E,F. Enlarged views of organ of Corti in Tbx1wdml/wdml mutants at 5 months old 
show reduced endolymph volume (red asterisk), collapsed ressiner’s membrane (black arrow), and no stria 
vascularis (white arrow) in comparison to the controls.   
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Figure 3.4 Paint fills of inner ears from Tbx1wdml/wdml mutant and control mice 
Paint fills of the membranous labyrinths of inner ears from an E14.5-stage Tbx1wdml/+ (control) embryo and two 
littermate Tbx1wdml/wdml (mutant) embryos. The endolymphatic sac (es), endolymphatic duct (ed), utricle (u), 
saccule (s), and cochlear duct (cd) in the two mutant inner ears appear to be normal compared with the control. 
Posterior semicircular canal (psc) is fused with common crus as show by the white arrow in two of the mutant ears.  
 
3.3.3 TBX1 expression in postnatal mouse inner ear  
 Tbx1 expression previously has been studied in embryos; however, there is no report of Tbx1 
expression during early postnatal stages. We used TBX1 antibody to detect and localize TBX1 expression 
in the inner ear of Tbx1wdml mutant mice and littermate controls at P3 and P15 (Figure 3.5). TBX1 
expression is observed in marginal cells of the stria vascularis in the cochlea and in the dark cells of the 
crista ampullaris in the vestibular system of mutant and control inner ears at P3; however, this 
expression disappears by P15. TBX1 expression also was observed in hair cells and supporting cells of the 
crista ampullaris of mutant and control mice at both P3 and P15. TBX1 immunostaining intensity and 
localization in Tbx1wdml mutant mice was the same as that seen in the control mice, indicating that the 
p.D212G missense mutation does not affect the stability or localization of the TBX1 protein.   
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Figure 3.5 The expression of TBX1 in the postnatal mouse inner ear 
(A-C) Immunolabeling on transverse sections through the cochlea reveals that TBX1 is expressed in the stria 
vascularis (white arrow) in both mutant and control mice (A-B) and in the vestibular dark cells (white arrowhead) 
of both mutant and control mice (D-E). No expression of TBX1 is detected in the stria vascularis (C, white arrow) 
and dark cells (F, white arrowhead) at P15 in the wild type mice. 
 
3.3.4 Absence of marginal cell markers in the Tbx1wdml/wdml mutant mice 
 Because the stria vascularis appeared abnormal in mutant mice, markers for stria vascularis 
marginal cells (Kcnq1), intermediate cells (Kcnj10/Dct), and basal cells (Glut1/Cldn11) were used to 
examine the effects of the Tbx1wdml mutation on the cellular structure of the stria vascularis. Because the 
stria vascularis was undeveloped at P7, we chose to examine these cell types in P0 and P3 mice. 
Immunohistochemical results showed that the marginal cell marker KCNQ1 is absent from the wdml 
mutant mice and expression of the capillary endothelial cell marker (GLUT1) appears to be weaker and 
within a slightly reduced region (Figure 3.6). Results from mRNA in situ hybridization experiments 
showed Esrrb expression in marginal cells of E16.5 and P3 wild type mice but a lack of expression in age-
matched mutant mice. Expression of Dct, (an intermediate cell marker) was reduced in the stria 
vascularis of wdml mutant mice (Figure 3.6).  
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Figure 3.6 Immunodetection of KCNQ1, KCNJ10, and GLUT1 in P0 Tbx1wdml/wdml and Tbx1wdml/+ mouse cochlea 
KCNQ1, KCNJ10, and GLUT1 expression are detected in the marginal cells (A), intermediate cells (B), and basal cells 
(C), respectively, in the wild type mice. Reduced KCNQ1 expression is detected in the Tbx1wdml/wdml mice (D), while 
KCNJ10 and GLUT1 showed reduced expression in the Tbx1wdml/wdml mice (E-F).  
 
3.3.5 Gene expression differences caused by the Tbx1wdml mutation 
 As Tbx1 is a transcription factor, we wanted to know whether the Tbx1wdml mutation leads to a 
different gene expression profile in mutant mice. We applied RNA-seq to identify genes that showed 
inner ear expression differences between Tbx1wdml mutant and control E16.5 embryos and identified 379 
that are up regulated and 87 that are down regulated.  The genes whose expression levels were most 
affected by the Tbx1wdml mutation are listed in Table 3.2 (A full list of up regulated and downr egulated 
genes can be found in the Appendix A). Down regulation of Esrrb, and Dct were consistent with our in 
situ hybridization results (Figure 3.7) and provided evidence for the reliability of the RNA-seq results. 
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Table 3.2 The top 10 upregulated, top 5 downregulated, and five other downregulated DE 
genes (FDR ≤ 0.05) for Tbx1wdml/wdml and Tbx1wdml/+ mice as ranked by fold-change 
Gene  
Symbol Ensembl ID Log2 fold-change P Value 
FDR-Adjusted  
P value 
Myh2 ENSMUSG00000033196 4.223735601 2.44E-26 9.67E-24 
Myoz1 ENSMUSG00000068697 4.219894733 2.97E-51 4.59E-48 
Smtnl1 ENSMUSG00000027077 3.62677157 7.26E-19 1.58E-16 
Mylk2 ENSMUSG00000027470 3.315103192 4.84E-19 1.10E-16 
Ckm ENSMUSG00000030399 3.258077476 7.67E-55 1.48E-51 
Myh8 ENSMUSG00000055775 3.118427271 3.72E-53 6.40E-50 
Hspb3 ENSMUSG00000051456 3.05773731 1.00E-12 1.28E-10 
Col6a4 ENSMUSG00000032572 2.968700531 2.13E-22 6.59E-20 
Trim54 ENSMUSG00000062077 2.914416126 3.17E-14 4.67E-12 
Tnnt3 ENSMUSG00000061723 2.91225841 9.75E-46 1.26E-42 
Dlx3 ENSMUSG00000001510 -1.30775381 0.001061858 0.035029985 
Aldh1a2 ENSMUSG00000013584 -1.38788924 1.68E-05 0.000890633 
Dct ENSMUSG00000022129 -1.470836677 3.56E-07 2.54E-05 
Otx2 ENSMUSG00000021848 -1.852520264 6.51E-14 9.24E-12 
Esrrb ENSMUSG00000021255 -2.585855096 3.19E-35 2.06E-32 
Bsnd ENSMUSG00000025418 -4.12050993 5.75E-22 1.65E-19 
Pomc ENSMUSG00000020660 -4.227201537 1.93E-42 1.87E-39 
Kcne2 ENSMUSG00000039672 -5.820402262 1.26E-35 8.45E-33 
Ttr ENSMUSG00000061808 -9.422410447 4.39E-170 1.13E-166 
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3.4 Discussion 
The wdml mutation carries a missense mutation that changes the amino acid aspartic acid to glycine. 
The aspartic acid altered by the Tbx1wdml missense mutation is evolutionarily highly conserved, and both 
the PolyPhen 2 (http://genetics.bwh.harvard.edu/pph2/) and SIFT (http://sift.jcvi.org/) computer 
programs predict that the p.D212G substitution is probably damaging to protein function. The wdml 
mutation occurs in the T-box domain, which is highly conserved in all members of the T-box family. The 
T-box includes the DNA binding region of the protein but also contains sites of protein interactions. TBX1 
localization is not affected by the Tbx1wdml mutation (Figure 3.5), indicating that the mutant protein is 
stable and properly localized. This hypomorphic nature of the mutation can explain the less severe 
phenotype of Tbx1wdml mutant mice compared to that of Tbx1 knockout mice. The hypomorphic Tbx1wdml 
mutation may affect protein conformation or interactions with co-regulatory proteins that affect 
particular aspects of TBX1 function. 
 
Figure 3.7 Examination of Esrrb, Raldh2, and Dct expression in the Tbx1wdml mice and wild type mice with in 
situ hybridization 
Esrrb, Dct, and Raldh2 expression is detected in the stria vascularis in the wild type mice (A, C, E, G).  Esrrb and 
Raldh2 expression is undetectable in the Tbx1wdml mice (B, D, F), while reduced Dct expression is observed in 
the Tbx1wdml mice (H). Scale bar = 20μm.  
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 In contrast to the undeveloped inner ear of Tbx1 knockout mice, the inner ear of B6-Tbx1wdml 
mutant mice is fully developed but with abnormalities very similar to those of Esrrb-/- [103], Kcne1-/- [80, 
82], and Kcnq1-/- [104] mice; all exhibit reduced endolymph volume and collapsed Reisnner’s membrane 
at early postnatal stages and hearing impairment and vestibular dysfunction at adult age. Potassium 
channel proteins KCNE1 and KCNQ1 are coexpressed in the apical membrane of both marginal cells and 
dark cells, and release K+ to the endolymph [80, 105]. ESRRB, an estrogen-related nuclear receptor, 
controls the expression of multiple ion channel and transporter genes in strial marginal cells and 
vestibular dark cells [103]. Chen and colleagues [103] reported that Kcne1, Kcnq1, and Dct are down 
regulated in Esrrb-/- mice. They proposed that Esrrb is important for cell fate determination, as there is a 
cell fate change of marginal cells toward intermediate cells in Esrrb-/- mice [103]. Our results (Figure 3.7) 
show an absence of Esrrb expression in the stria vascularis of Tbx1wdml mutant mice as early as E16.5, 
indicating that Tbx1 is a direct or indirect upstream regulator of Essrb expression. Previous to this 
discovery, Esrrb was the only gene known to control development of the endolymph-producing 
epithelial cells of the inner ear. 
 Previous studies have not examined TBX1 expression beyond E18.5, Our results show that TBX1 
is expressed in the marginal cells of the stria vascularis and the dark cells of the crista ampullaris in both 
mutant and control mice at P3. Interestingly, expression in these cells disappears between P3 and P15 
(Figure 3.5), suggesting a transient function of TBX1 in the early postnatal stage. The cochlear marginal 
cells and vestibular dark cells are responsible for K+ transport to the endolymph of the inner ear and 
possess many similarities. Consistent with the marginal cell localization of TBX1, there was a lack of 
expression of the marginal cell marker KCNQ1 in Tbx1wdml mutants and reduced expression of 
intermediate and basal cell markers, which are probably secondary effects of the marginal cell defect. 
Together, these data support an important role for Tbx1 in marginal cell maturation and stria vascularis 
development and in the maturation and function of vestibular dark cells. We also found TBX1 expression 
 
 
67 
in the hair cells and supporting cells of the crista ampullaris at both P3 and P15 (Figure 3.5). Our TBX1 
protein localization results agree with results deduced from reporter gene β-gal activity in Tbx1+/lacZ 
mice, where expression also was detected during late development of the ear (E18.5) in marginal cells of 
the stria vascularis and in hair cells and adjacent nonsensory dark cells of the crista ampullaris [106].  
Lineage analysis of the late otocyst stage of mouse inner ears indicates that vestibular hair cells and 
supporting cells in the posterior crista are clonally related [107]. In addition, the lineage-tracing data 
raise the possibility that nonsensory epithelial cells bordering the crista may be clonally related to the 
vestibular sensory epithelium. These results may be related to our finding that TBX1 is expressed in 
sensory hair cells and supporting cells and also in the adjacent nonsensory dark cells of the crista in P3 
mice, followed by a loss of the nonsensory dark cell expression by P15 (Figure 3.5). 
 Paintfills of the membranous labyrinths of E14.5 inner ears of B6-Tbx1wdml/wdml mice revealed 
nonresorption of the fusion plate of the posterior semicircular canal, a vestibular phenotype similar to 
that observed in Foxg1-/- mice [108]. Although Tbx1wdml mutant mice have a normal looking cochlea, 
Foxg1-/- mutant mice have a shortened cochlea, possibly because Foxg1 acts upstream of the Tbx1 gene. 
At the beginning of semicircular canal formation, fusion plates are formed through attachment of 
apposing lateral and medial epithelial extrusions of the dorsal otic vesicle. Epithelial cells at the fusion 
plate intercalate to form a single sheet and disappear through a process of resorption, either through 
apoptosis or retraction of the cells to the remaining canal pouch epithelium at the outer rim, to form the 
fluid-filled canal.  Bone morphogenetic protein 4 (BMP4) marks the incipient posterior crista by E11.5, 
followed shortly thereafter by BMP4 delineation of the anterior and lateral cristae, which may share a 
common origin as evidenced by the single BMP4-positive area in the anterior portion of the otocyst that 
is later seen as two distinct domains[109]. The crista has been hypothesized to induce the formation of 
the associated semicircular canal structure [108]. Reduced function of TBX1 in the posterior crista of 
Tbx1vtx mutants, therefore, may possibly be the underlying cause for the incomplete formation of the 
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posterior canal and ampulla during otic development.  
 To elucidate the molecular mechanisms underlying the Tbx1wdml mutant phenotype, we 
performed RNA-seq with inner ears from mutant and control E16.5 embryos, the age at which stria 
vascularis development begins. We identified a number of genes that are expressed in the stria 
vascularis and are involved in stria development and function (Table 3.2). The RNA-seq results showed 
down regulation of Esrrb, which has a very similar expression pattern in the inner ear as Tbx1. Our in situ 
RNA hybridization results also showed a down regulation of Esrrb  (Figure 3.7), supporting the reliability 
of the RNA-Seq data. We observed drastic reductions in Kcne1 and Kcne2 expression, which is not 
surprising because KCNE1 and KCNQ1 form a potassium channel complex and are important for K+ 
secretion into the inner ear endolymph. Bsnd and Dct, markers for stria vascularis basal cell and 
intermediate cells, respectively, are also down regulated in the Tbx1wdml mutant mice as is Dlx3, a 
member of the distaless homeobox family of transcription factors, which are known to play important 
roles in the developing vestibular system of the inner ear [110]. Surprisingly more genes were up 
regulated than down regulated by the Tbx1wdml mutation, suggesting that TBX1 inhibits expression of 
more genes than it enhances in the E16.5 inner ear. 
 We hypothesize that Tbx1 is important for marginal cell fate determination. Esrrb is down 
regulated in Tbx1wdml mutant mice, as shown from our in situ RNA hybridization and RNA-seq results, 
and therefore acts as a direct or indirect downstream target of Tbx1. Chen and colleagues showed a 
change of marginal cell fate toward intermediate cell in Esrrb-/- mice [103]. If Tbx1 regulates Esrrb 
expression and ESRRB regulates marginal cell fate determination, we can predict that marginal cell 
differentiation cannot be achieved in the Tbx1wdml mutant mice, leading to failed marginal cell 
maturation and interdigitation and subsequent failure of stria vascularis development. Another possible 
but less likely explanation for the undeveloped stria vascularis of mutant mice is that Tbx1 is required for 
cell proliferation and survival rather than cell fate determination.  
 
 
69 
 TBX1 has been shown to regulate retinoic acid (RA) metabolic genes during cochlear 
morphogenesis [111], and Aldh1a2 (Raldh2), which encodes the RA-synthesizing enzyme retinaldehyde 
dehydrogenase 2, was found to be expressed in the stria vascularis, Reissner’s membrane and dark cells 
of the inner ear [112-114]. Our in situ RNA hybridization analysis showed that Raldh2 expression is down 
regulated in in the stria vascularis of Tbx1wdml mutant mice (Figure 3.7), consistent with previous studies 
of RALDH2 localization, and suggesting that RA may be specifically synthesized in this part of the cochlea 
[112]. RA secreted by the marginal cells may be required for vascularization in the stria vascularis and 
establishment of the inner ear blood-labyrinth barrier, as supported by a study showing that RA 
contributes to blood–brain barrier maturation [115]. Radial glial cells in fetal human brain tissue express 
high levels of Raldh2 and tightly associate with the developing brain vasculature that expresses the RA 
receptor β during embryogenesis [116]. Raldh2 expression may play a similar role in stria vascularis 
vasculature maturation. 
 Studies of prostate cancer patients and animal models have identified associations between 
Tbx1 and Raldh2 [117]. They showed that methylation of Tbx1 regulates the RA signaling pathway 
through downregulation of Raldh2. Raldh2 null mice are embryonic lethal [118], and a hypomorphic 
Raldh2 mutation caused decreased RA synthesis and a DiGorge syndrome-like phenotype in the mice 
[119]. Expression of Raldh2 (Aldh1a2) was reported to be down regulated in mice with an Esrrb loss of 
function mutation [103]. It is proposed that ESRRB heterodimerizes or directly cooperates with RAR at 
direct repeat hormone response element (HRE) motifs, facilitating stable binding events before and/or 
after RA signaling [120]. 
 Our RNA-seq data showed downregulation of Dlx3 in Tbx1wdml mutant E16.5 embryos. Dlx3 is 
expressed in the dorsal region of the otic vesicle at E12.5, and its expression was lost in the developing 
semicircular canals of mesodermal Tbx1 loss of function mutant mice [110]. A recent report using an 
oral squamous cell carcinoma line treated with all-trans retinoic acid suggests that Dlx3 is negatively 
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regulated by RA [121]. Collectively, these data suggest that Tbx1 may interact with the RA signaling 
pathway to regulate semicircular canal formation and stria vascularis maturation. 
3.5 Summary 
 Tbx1 not only has a global effect on inner ear development evidenced by failed inner ear 
morphogenesis at the otocyst stage in the Tbx1 homozygous knockout mice, but also plays possible 
specific roles for semicircular canal and stria vascularis development as suggested by Tbx1 expression in 
the marginal cells of the stria vascularis and the dark cells of the crista ampullaris at later embryo stages. 
As no inner ear is formed in germline or conditional Tbx1 knockout mice, Tbx1wdml mice provide the first 
model that allow us to study Tbx1 function during semicircular canal and stria vascularis development. 
The stria vascularis phenotype of the Tbx1wdml mice at postnatal stages makes it a good model to 
examine the molecular network that regulates stria vascularis development and maturation. Various 
hearing disorders in human patients are associated with stria vascularis dysfunction; for example, 
mutation in the KCNQ1 gene cause long QT syndrome, SESAME Syndrome is associated with mutations 
in the human JCNJ10 gene, and Bartter syndrome is associated with mutations in the BSND gene. 
Investigation of the Tbx1wdml mutation will provide us more knowledge of the molecular network that 
regulates stria vascularis development and function and opens a new avenue for developing therapeutic 
approaches to treat hearing disorders associated with its dysfunction.  
3.6 Future directions 
 Posterior semicircular canal malformation is observed in the E14.5 mutant inner ear; however, it 
is unclear whether it is due to stopped or delayed development. To answer that question, two more 
ages of the Tbx1wdml inner ear will be observed by paintfill analysis: E16.5 and P0. To further investigate 
the undeveloped stria vascularis observed in the Tbx1wdml mice, we will apply transmission electron 
microscope (TEM) to observe the microstructure of the cell layers within the mutant stria vascularis. 
Failed development of the mutant stria vascularis is very likely because undifferentiated marginal cells 
 
 
71 
are not able to interdigitate with intermediate cells and the vasculature network. We hypothesize that 
interactions of TBX1 with other proteins that are important for inner ear development are disrupted by 
the wdml mutation. We therefore propose to use an unbiased approach (yeast two hybridization) to 
screen for proteins that interact with TBX1 in E16.5 inner ears. We will localize the identified protein in 
the inner ear if no data is available, and confirm TBX1 interaction with these candidate proteins using 
co-immunoprecipitation or pull down assay. Lastly, we will detect whether the protein interactions 
between TBX1 and the candidate proteins are disrupted by the wdml mutation.  
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CHAPTER 4 THESIS SUMMARY 
Three new mouse mutations: Enpp1asj, Atp6v1b1vtx, and Tbx1wdml, are reported in this 
dissertation. All three mutations lead to severe hearing loss/deafness in the mutant mice, but are due to 
different underlying pathologies.  
Chapter 1: The Enpp1asj mutation causes middle ear inflammation that is associated with 
abnormal mineralization and calcification in the asj mutant mice. Inflammation causes 
transdifferentiation of ciliary epithelial cells into goblet cells, which leads to excessive mucus secretion in 
the middle ear cavity. Reduction of ciliary epithelial cells impair the clearance function of the ciliary 
epithelia. Both factors combined lead to accumulation of mucus in the middle ear cavity that causes 
progressive conductive hearing loss in the asj mutant mice. Another factor that contributes to the 
conductive hearing loss in the asj mice is tympanosclerosis, a subtype of otosclerosis, which is a 
common middle ear condition characterized by abnormal bone remodeling in the middle ear. 
Calcification of middle ear soft tissues, such as tympanic membrane, and mineralization of middle ear 
ossicles, are observed in patients with tympanoslerosis in addition to abnormal middle ear bone 
remodeling.  
Chapter 2: The Atp6v1b1vtx mutation leads to an enlargement of the endolymphatic duct and sac 
of the inner ear, which results in drastically reduced endolymphatic potential (EP), deafness and 
vestibular dysfunction in homozygous mutant mice. The vtx mutation arose on the MRL-MpJ 
background, which has a strong deleterious effect on its auditory phenotype, as opposed to a previously 
reported Atp6v1b1 KO mouse on a B6 background that has normal hearing. MRL-Atp6v1b1vtx mutant 
mice provide a new genetic model for some clinical cases of nonsyndromic deafness with enlarged 
vestibular aqueducts. We attempted to map the loci that contribute to hearing loss phenotype in the 
MRL-vtx mice, and found that the modifier effects on hearing loss are derived from multiple loci rather 
than a single locus with large effect. Genome-wide linkage analysis revealed a region on chromosome 13 
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that contains over 400 genes. Two candidate genes, Slc9a3 and Slc12a7, were picked based on their 
expression pattern in the inner ear and the association with inner ear ion homeostasis. We did not 
detect either DNA sequence or mRNA expression differences in these genes between MRL and B6 mice, 
indicating that they are not likely the modifiers. Besides the large candidate gene pool, complete 
sequence of the MRL strain is not available, making the effort to narrow down the candidate region and 
identify the modifiers more challenging.  
Chapter 3: The Tbx1wdml mutation leads to semicircular canal malformation and undeveloped 
stria vascularis in the inner ears of mutant mice, which contribute to the circling and deafness 
phenotype of these mice. In contrast to Atp6v1b1vtx mice (Chapter 2), which have dramatically increased 
endolymph volume, Tbx1wdml mice have greatly reduced endolymph volume, due to lack of stria 
vascularis function. Initial efforts showed that the wdml mutation does not affect the stability and 
localization of TBX1 protein in the mouse inner ear, and that TBX1 is only expressed in the stria 
vascularis and vestibular dark cells at the early postnatal stage. Reduced expression of the orphan 
nuclear receptor Esrrb in the Tbx1wdml mutant mice suggest that Tbx1 is an upstream regulator of the 
gene network that regulates stria vascularis development.  
We used a forward genetics approach to identify these new mouse mutations that affect ear 
development and function. This approach relies on the abundant mutant mouse resources available 
from the Jackson Laboratory. Besides the three genes reported in this dissertation, other genes such as 
Clic5, Tmhs, and Duox2, were identified using this strategy. These new mouse mutations were identified 
either by their vestibular phenotype, which is usually associated with hearing loss (though there are 
exceptions), or by hearing screen with auditory brainstem response measurement. Causative mutations 
were identified by linkage association analysis with either intercross or backcross mice.  
One of the advantages of the forward genetics approach is that it can identify new alleles that 
can reveal a particular protein's role in a specific process in a way that deletion of the protein cannot. 
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Hypomorphic alleles that affect certain aspects of protein function or alter protein structure can lead to 
less severe phenotypes than KO alleles and therefore allow us to study specific functions of these genes. 
Take the Tbx1wdml mutation as an example. The association of TBX1 with human DiGeorge syndrome 
drove the creation of Tbx1 KO and conditional KO mice. However, these mice could only tell us that 
TBX1 is crucial for inner ear morphogenesis as the inner ear does not develop past the E10 otocyst stage 
in these mutant mice. Does TBX1 have other functions during inner ear development? This question 
cannot be addressed with the KO mutant mice because they do not have a fully developed inner ear. 
Furthermore, studies showed that TBX1 is expressed in the stria vascularis and vestibular dark cells 
during late embryo stage, suggesting potential involvement of TBX1 in the development and/or function 
of these structures. The wdml point mutation in the Tbx1 gene causes circling behavior and deafness in 
the mutant mice. Inner ears of Tbx1wdml mutant mice fully develop but show pathologies in the stria 
vascularis and vestibule that correspond to their expression patterns. This mutation allows us to study 
Tbx1 function during inner ear development and identify proteins that interact with TBX1 and regulate 
the genetic network that regulates inner ear development.  
Another advantage of the forward genetics approach is that it allows us to investigate strain 
background effects on the mutant phenotype.. Most engineered mutations are on the B6 background, 
which limits discovery of genetic background effects on mutant phenotypes. For example, mutations in 
the ATP6V1B1 gene were reported in human patients with distal renal tubular acidosis with hearing loss, 
but a mouse KO of  Atp6v1b1 on the B6 background did not exhibit any renal or auditory deficits. The vtx 
mutation in the Atp6v1b1 gene on a MRL background, in contrast, recapitulates the hearing loss 
phenotype observed in patients with distal renal tubular acidosis, indicating that the MRL background 
has a profound effect on the auditory phenotype associated with Atp6v1b1 mutation in mice, and helps 
to explain the phenotype variability associated with human ATP6V1B1 mutations.  
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In summary, the three mutations reported here provide valuable models to study common 
middle ear condition (otitis media), sensorineural hearing loss associated with enlarged vestibular 
aqueduct, and hearing loss associated with human DiGeorge syndrome. These missense mutations 
identified with a forward genetics approach suggest that despite of the emerging of new technique like 
CRISPR, it is still a valuable method to identify new genes that cause hearing loss phenotype. Previous 
studies predicted that hundreds of genes related to inner ear development are waiting to be discovered, 
and these discoveries can be aided by the forward genetics approach. These mouse models are also 
valuable tools for testing gene therapies. For example, the same amino acid change was reported in 
human patients as was discovered in the Tbx1wdml mice. This missense mutation provides an easy target 
for gene therapy and will be very informative for future clinical trials. Another good model is the 
Atp6v1b1vtx mice and its modifier genes, which can provide new insight into genetic background effects 
underlying the phenotypic variability in human patients and the underlying mechanisms and pave a new 
avenue for therapeutic approaches.  
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